10-K 1 kmb-20231231.htm 10-K FORM kmb-20231231
0000055785false12/312023FYhttp://fasb.org/us-gaap/2023#OtherAssetshttp://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#DebtCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations00000557852023-01-012023-12-310000055785us-gaap:CommonStockMember2023-01-012023-12-310000055785kmb:A0.625NotesDue2024Member2023-01-012023-12-3100000557852023-06-30iso4217:USD00000557852024-01-31xbrli:shares00000557852022-01-012022-12-3100000557852021-01-012021-12-31iso4217:USDxbrli:shares00000557852023-12-3100000557852022-12-310000055785us-gaap:CommonStockMember2020-12-310000055785us-gaap:AdditionalPaidInCapitalMember2020-12-310000055785us-gaap:TreasuryStockCommonMember2020-12-310000055785us-gaap:RetainedEarningsMember2020-12-310000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000055785us-gaap:NoncontrollingInterestMember2020-12-3100000557852020-12-310000055785us-gaap:RetainedEarningsMember2021-01-012021-12-310000055785us-gaap:NoncontrollingInterestMember2021-01-012021-12-310000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310000055785us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310000055785us-gaap:TreasuryStockCommonMember2021-01-012021-12-310000055785us-gaap:CommonStockMember2021-12-310000055785us-gaap:AdditionalPaidInCapitalMember2021-12-310000055785us-gaap:TreasuryStockCommonMember2021-12-310000055785us-gaap:RetainedEarningsMember2021-12-310000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000055785us-gaap:NoncontrollingInterestMember2021-12-3100000557852021-12-310000055785us-gaap:RetainedEarningsMember2022-01-012022-12-310000055785us-gaap:NoncontrollingInterestMember2022-01-012022-12-310000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310000055785us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310000055785us-gaap:TreasuryStockCommonMember2022-01-012022-12-310000055785us-gaap:CommonStockMember2022-12-310000055785us-gaap:AdditionalPaidInCapitalMember2022-12-310000055785us-gaap:TreasuryStockCommonMember2022-12-310000055785us-gaap:RetainedEarningsMember2022-12-310000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000055785us-gaap:NoncontrollingInterestMember2022-12-310000055785us-gaap:RetainedEarningsMember2023-01-012023-12-310000055785us-gaap:NoncontrollingInterestMember2023-01-012023-12-310000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310000055785us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310000055785us-gaap:TreasuryStockCommonMember2023-01-012023-12-310000055785us-gaap:CommonStockMember2023-12-310000055785us-gaap:AdditionalPaidInCapitalMember2023-12-310000055785us-gaap:TreasuryStockCommonMember2023-12-310000055785us-gaap:RetainedEarningsMember2023-12-310000055785us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000055785us-gaap:NoncontrollingInterestMember2023-12-310000055785us-gaap:BuildingMember2023-12-310000055785srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2023-12-310000055785us-gaap:MachineryAndEquipmentMembersrt:MaximumMember2023-12-310000055785us-gaap:ComputerSoftwareIntangibleAssetMember2023-12-310000055785srt:MinimumMemberus-gaap:TrademarksMember2023-12-310000055785us-gaap:TrademarksMembersrt:MaximumMember2023-12-310000055785srt:MinimumMemberkmb:PatentsDevelopedTechnologiesOtherIntangibleAssetsMember2023-12-310000055785kmb:PatentsDevelopedTechnologiesOtherIntangibleAssetsMembersrt:MaximumMember2023-12-310000055785kmb:SaleOfBrazilTissueAssetsMember2023-04-012023-06-300000055785kmb:BeforeTaxMemberkmb:SaleOfBrazilTissueAssetsMember2023-04-012023-06-300000055785kmb:ThinxIncMember2022-01-012022-03-310000055785us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesMembercountry:AR2023-01-012023-12-31xbrli:pure0000055785us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesMembercountry:TR2023-01-012023-12-310000055785kmb:A2018GlobalRestructuringProgramMember2023-01-012023-12-310000055785kmb:A2018GlobalRestructuringProgramMember2018-01-012021-12-31kmb:Employee0000055785kmb:BeforeTaxMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012021-12-310000055785kmb:AfterTaxMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012021-12-310000055785kmb:CashChargesMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012021-12-310000055785kmb:BeforeTaxMemberkmb:NoncashchargesMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012021-12-310000055785kmb:BeforeTaxMemberus-gaap:CostOfSalesMemberkmb:A2018GlobalRestructuringProgramMember2021-01-012021-12-310000055785kmb:BeforeTaxMemberus-gaap:CostOfSalesMemberkmb:A2018GlobalRestructuringProgramMember2020-01-012020-12-310000055785kmb:BeforeTaxMemberus-gaap:CostOfSalesMemberkmb:A2018GlobalRestructuringProgramMember2019-01-012019-12-310000055785kmb:BeforeTaxMemberus-gaap:CostOfSalesMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012018-12-310000055785kmb:BeforeTaxMemberus-gaap:CostOfSalesMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012021-12-310000055785kmb:BeforeTaxMemberkmb:AssetwriteoffsMemberus-gaap:CostOfSalesMemberkmb:A2018GlobalRestructuringProgramMember2021-01-012021-12-310000055785kmb:BeforeTaxMemberkmb:AssetwriteoffsMemberus-gaap:CostOfSalesMemberkmb:A2018GlobalRestructuringProgramMember2020-01-012020-12-310000055785kmb:BeforeTaxMemberkmb:AssetwriteoffsMemberus-gaap:CostOfSalesMemberkmb:A2018GlobalRestructuringProgramMember2019-01-012019-12-310000055785kmb:BeforeTaxMemberkmb:AssetwriteoffsMemberus-gaap:CostOfSalesMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012018-12-310000055785kmb:BeforeTaxMemberkmb:AssetwriteoffsMemberus-gaap:CostOfSalesMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012021-12-310000055785kmb:BeforeTaxMemberkmb:A2018GlobalRestructuringProgramMemberkmb:MarketingResearchAndGeneralExpensesMember2021-01-012021-12-310000055785kmb:BeforeTaxMemberkmb:A2018GlobalRestructuringProgramMemberkmb:MarketingResearchAndGeneralExpensesMember2020-01-012020-12-310000055785kmb:BeforeTaxMemberkmb:A2018GlobalRestructuringProgramMemberkmb:MarketingResearchAndGeneralExpensesMember2019-01-012019-12-310000055785kmb:BeforeTaxMemberkmb:A2018GlobalRestructuringProgramMemberkmb:MarketingResearchAndGeneralExpensesMember2018-01-012018-12-310000055785kmb:BeforeTaxMemberkmb:A2018GlobalRestructuringProgramMemberkmb:MarketingResearchAndGeneralExpensesMember2018-01-012021-12-310000055785kmb:BeforeTaxMemberus-gaap:OtherIncomeMemberkmb:A2018GlobalRestructuringProgramMember2021-01-012021-12-310000055785kmb:BeforeTaxMemberus-gaap:OtherIncomeMemberkmb:A2018GlobalRestructuringProgramMember2020-01-012020-12-310000055785kmb:BeforeTaxMemberus-gaap:OtherIncomeMemberkmb:A2018GlobalRestructuringProgramMember2019-01-012019-12-310000055785kmb:BeforeTaxMemberus-gaap:OtherIncomeMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012018-12-310000055785kmb:BeforeTaxMemberus-gaap:OtherIncomeMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012021-12-310000055785kmb:BeforeTaxMemberus-gaap:NonoperatingIncomeExpenseMemberkmb:A2018GlobalRestructuringProgramMember2021-01-012021-12-310000055785kmb:BeforeTaxMemberus-gaap:NonoperatingIncomeExpenseMemberkmb:A2018GlobalRestructuringProgramMember2020-01-012020-12-310000055785kmb:BeforeTaxMemberus-gaap:NonoperatingIncomeExpenseMemberkmb:A2018GlobalRestructuringProgramMember2019-01-012019-12-310000055785kmb:BeforeTaxMemberus-gaap:NonoperatingIncomeExpenseMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012018-12-310000055785kmb:BeforeTaxMemberus-gaap:NonoperatingIncomeExpenseMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012021-12-310000055785kmb:BeforeTaxMemberkmb:A2018GlobalRestructuringProgramMember2021-01-012021-12-310000055785kmb:BeforeTaxMemberkmb:A2018GlobalRestructuringProgramMember2020-01-012020-12-310000055785kmb:BeforeTaxMemberkmb:A2018GlobalRestructuringProgramMember2019-01-012019-12-310000055785kmb:BeforeTaxMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012018-12-310000055785kmb:A2018GlobalRestructuringProgramMember2021-01-012021-12-310000055785kmb:A2018GlobalRestructuringProgramMember2020-01-012020-12-310000055785kmb:A2018GlobalRestructuringProgramMember2019-01-012019-12-310000055785kmb:A2018GlobalRestructuringProgramMember2018-01-012018-12-310000055785kmb:AfterTaxMemberkmb:A2018GlobalRestructuringProgramMember2021-01-012021-12-310000055785kmb:AfterTaxMemberkmb:A2018GlobalRestructuringProgramMember2020-01-012020-12-310000055785kmb:AfterTaxMemberkmb:A2018GlobalRestructuringProgramMember2019-01-012019-12-310000055785kmb:AfterTaxMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012018-12-310000055785us-gaap:NoncontrollingInterestMemberkmb:AfterTaxMemberkmb:A2018GlobalRestructuringProgramMember2021-01-012021-12-310000055785us-gaap:NoncontrollingInterestMemberkmb:AfterTaxMemberkmb:A2018GlobalRestructuringProgramMember2020-01-012020-12-310000055785us-gaap:NoncontrollingInterestMemberkmb:AfterTaxMemberkmb:A2018GlobalRestructuringProgramMember2019-01-012019-12-310000055785us-gaap:NoncontrollingInterestMemberkmb:AfterTaxMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012018-12-310000055785us-gaap:NoncontrollingInterestMemberkmb:AfterTaxMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012021-12-310000055785kmb:AfterTaxMemberus-gaap:ParentMemberkmb:A2018GlobalRestructuringProgramMember2021-01-012021-12-310000055785kmb:AfterTaxMemberus-gaap:ParentMemberkmb:A2018GlobalRestructuringProgramMember2020-01-012020-12-310000055785kmb:AfterTaxMemberus-gaap:ParentMemberkmb:A2018GlobalRestructuringProgramMember2019-01-012019-12-310000055785kmb:AfterTaxMemberus-gaap:ParentMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012018-12-310000055785kmb:AfterTaxMemberus-gaap:ParentMemberkmb:A2018GlobalRestructuringProgramMember2018-01-012021-12-310000055785kmb:ThinxIncMember2022-03-310000055785kmb:ThinxIncMember2023-03-310000055785kmb:ThinxIncMember2023-01-012023-03-310000055785kmb:ThinxIncMember2023-12-310000055785kmb:BeforeTaxMemberkmb:ThinxIncMember2022-01-012022-03-310000055785kmb:ThinxIncMemberkmb:AfterTaxMember2022-01-012022-03-310000055785kmb:ThinxIncMember2023-04-012023-06-300000055785kmb:ThinxIncMember2023-10-012023-12-310000055785kmb:ThinxIncMember2023-01-012023-12-310000055785us-gaap:RetainedEarningsMemberkmb:ThinxIncMember2023-01-012023-12-310000055785kmb:AfterTaxMemberkmb:SaleOfBrazilTissueAssetsMember2023-04-012023-06-300000055785kmb:PersonalCareMember2021-12-310000055785kmb:ConsumerTissueMember2021-12-310000055785kmb:KCProfessionalMember2021-12-310000055785kmb:PersonalCareMember2022-01-012022-12-310000055785kmb:ConsumerTissueMember2022-01-012022-12-310000055785kmb:KCProfessionalMember2022-01-012022-12-310000055785kmb:PersonalCareMember2022-12-310000055785kmb:ConsumerTissueMember2022-12-310000055785kmb:KCProfessionalMember2022-12-310000055785kmb:PersonalCareMember2023-01-012023-12-310000055785kmb:ConsumerTissueMember2023-01-012023-12-310000055785kmb:KCProfessionalMember2023-01-012023-12-310000055785kmb:PersonalCareMember2023-12-310000055785kmb:ConsumerTissueMember2023-12-310000055785kmb:KCProfessionalMember2023-12-310000055785kmb:BrandNamesMember2023-12-310000055785kmb:BrandNamesMember2022-12-310000055785kmb:TrademarksAndBrandNamesMember2023-12-310000055785kmb:TrademarksAndBrandNamesMember2022-12-310000055785us-gaap:OtherIntangibleAssetsMember2023-12-310000055785us-gaap:OtherIntangibleAssetsMember2022-12-3100000557852024-12-3100000557852023-04-012023-06-300000055785us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310000055785us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310000055785us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-12-310000055785us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310000055785kmb:NetAssetValueorItsEquivalentMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000055785kmb:NetAssetValueorItsEquivalentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310000055785us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310000055785us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310000055785us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000055785us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000055785us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310000055785us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310000055785us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000055785us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000055785kmb:NotesAndDebenturesMember2023-12-310000055785kmb:NotesAndDebenturesMember2022-12-310000055785kmb:IndustrialDevelopmentRevenueBondsMember2023-12-310000055785kmb:IndustrialDevelopmentRevenueBondsMember2022-12-310000055785kmb:BankLoansAndOtherFinancingsInVariousCurrenciesMember2023-12-310000055785kmb:BankLoansAndOtherFinancingsInVariousCurrenciesMember2022-12-310000055785kmb:A450NotesDueFebruary162033Member2023-12-310000055785kmb:A200NotesDueNovember22031Member2022-12-310000055785kmb:A200NotesDueNovember22031Member2023-12-310000055785kmb:CreditFacilityExpiringJune2026Member2023-12-310000055785kmb:CreditFacilityExpiringJune2023Member2023-12-310000055785us-gaap:EmployeeStockOptionMember2023-01-012023-12-310000055785kmb:TimeVestedRestrictedShareUnitsMember2023-01-012023-12-310000055785us-gaap:RestrictedStockMember2023-01-012023-12-310000055785us-gaap:ShareBasedCompensationAwardTrancheThreeMembersrt:MinimumMemberus-gaap:PerformanceSharesMember2023-01-012023-12-310000055785us-gaap:ShareBasedCompensationAwardTrancheThreeMemberus-gaap:PerformanceSharesMembersrt:MaximumMember2023-01-012023-12-310000055785us-gaap:EmployeeStockOptionMember2022-01-012022-12-310000055785us-gaap:EmployeeStockOptionMember2021-01-012021-12-310000055785us-gaap:EmployeeStockOptionMember2023-12-310000055785us-gaap:RestrictedStockMember2023-12-310000055785us-gaap:PerformanceSharesMember2023-12-310000055785us-gaap:PerformanceSharesMember2023-01-012023-12-310000055785us-gaap:EmployeeStockOptionMember2022-12-310000055785kmb:TimeVestedRestrictedShareUnitsMember2022-12-310000055785us-gaap:PerformanceSharesMember2022-12-310000055785kmb:TimeVestedRestrictedShareUnitsMember2023-12-310000055785us-gaap:RestrictedStockMember2022-01-012022-12-310000055785us-gaap:RestrictedStockMember2021-01-012021-12-310000055785srt:ScenarioForecastMember2024-12-310000055785srt:ScenarioForecastMember2034-12-310000055785srt:ScenarioForecastMember2034-01-012034-12-310000055785us-gaap:PensionPlansDefinedBenefitMember2022-12-310000055785us-gaap:PensionPlansDefinedBenefitMember2021-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310000055785us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-12-310000055785us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-12-310000055785us-gaap:PensionPlansDefinedBenefitMember2023-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-12-310000055785kmb:PrincipalPlansMember2023-12-310000055785kmb:PrincipalPlansMember2022-12-310000055785kmb:AllOtherPensionPlansMember2023-12-310000055785kmb:AllOtherPensionPlansMember2022-12-310000055785us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-12-310000055785srt:ScenarioForecastMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-12-310000055785kmb:PrincipalPlansMembersrt:ScenarioForecastMember2024-12-310000055785kmb:PrincipalPlansMemberus-gaap:EquitySecuritiesMembersrt:ScenarioForecastMember2024-12-310000055785kmb:PrincipalPlansMember2023-01-012023-12-310000055785kmb:PrincipalPlansMember2022-01-012022-12-310000055785kmb:PrincipalPlansMember2021-01-012021-12-310000055785kmb:PrincipalPlansMembersrt:ScenarioForecastMember2024-01-012024-12-310000055785kmb:PrincipalPlansMemberus-gaap:CashAndCashEquivalentsMember2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel2Member2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:USTreasuryAndGovernmentMember2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Member2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2023-12-310000055785kmb:PrincipalPlansMemberkmb:NonU.SSecuritizedMember2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:ForeignCorporateDebtSecuritiesMember2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:ForeignCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-12-310000055785kmb:PrincipalPlansMemberkmb:NetAssetValueorItsEquivalentMemberus-gaap:USTreasuryAndGovernmentMember2023-12-310000055785kmb:PrincipalPlansMemberkmb:NetAssetValueorItsEquivalentMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:ForeignCorporateDebtSecuritiesMemberkmb:NetAssetValueorItsEquivalentMember2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:DefinedBenefitPlanEquitySecuritiesUsMember2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:FairValueInputsLevel1Member2023-12-310000055785kmb:PrincipalPlansMemberkmb:InternationalEquityMember2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel1Member2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember2023-12-310000055785kmb:PrincipalPlansMemberkmb:GlobalEquityMember2023-12-310000055785kmb:PrincipalPlansMemberkmb:InsuranceContractMember2023-12-310000055785kmb:PrincipalPlansMemberkmb:InsuranceContractMemberus-gaap:FairValueInputsLevel3Member2023-12-310000055785kmb:PrincipalPlansMemberkmb:OtherMember2023-12-310000055785kmb:PrincipalPlansMemberkmb:OtherMemberus-gaap:FairValueInputsLevel1Member2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:FairValueInputsLevel1Member2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:FairValueInputsLevel2Member2023-12-310000055785kmb:PrincipalPlansMemberus-gaap:FairValueInputsLevel3Member2023-12-310000055785kmb:U.S.PensionPlanMember2023-12-310000055785kmb:U.S.PensionPlanMember2022-12-310000055785kmb:U.K.PensionPlanMember2023-12-310000055785kmb:U.K.PensionPlanMember2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:CashAndCashEquivalentsMember2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:CashAndCashEquivalentsMemberkmb:NetAssetValueorItsEquivalentMember2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:USTreasuryAndGovernmentMember2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:ForeignCorporateDebtSecuritiesMember2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:ForeignCorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310000055785kmb:PrincipalPlansMemberkmb:NetAssetValueorItsEquivalentMemberus-gaap:USTreasuryAndGovernmentMember2022-12-310000055785kmb:PrincipalPlansMemberkmb:NetAssetValueorItsEquivalentMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:ForeignCorporateDebtSecuritiesMemberkmb:NetAssetValueorItsEquivalentMember2022-12-310000055785kmb:PrincipalPlansMemberkmb:USEquityMember2022-12-310000055785kmb:PrincipalPlansMemberkmb:USEquityMemberus-gaap:FairValueInputsLevel1Member2022-12-310000055785kmb:PrincipalPlansMemberkmb:InternationalEquityMember2022-12-310000055785kmb:PrincipalPlansMemberkmb:InternationalEquityMemberus-gaap:FairValueInputsLevel1Member2022-12-310000055785kmb:PrincipalPlansMemberkmb:NetAssetValueorItsEquivalentMemberkmb:NonUSEquityMember2022-12-310000055785kmb:PrincipalPlansMemberkmb:NetAssetValueorItsEquivalentMemberkmb:GlobalEquityMember2022-12-310000055785kmb:PrincipalPlansMemberkmb:InsuranceContractMember2022-12-310000055785kmb:PrincipalPlansMemberkmb:InsuranceContractMemberus-gaap:FairValueInputsLevel3Member2022-12-310000055785kmb:PrincipalPlansMemberkmb:OtherMember2022-12-310000055785kmb:PrincipalPlansMemberkmb:OtherMemberus-gaap:FairValueInputsLevel1Member2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:FairValueInputsLevel1Member2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:FairValueInputsLevel2Member2022-12-310000055785kmb:PrincipalPlansMemberus-gaap:FairValueInputsLevel3Member2022-12-310000055785srt:ScenarioForecastMemberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000055785us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000055785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000055785us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-12-310000055785us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-12-310000055785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-012022-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-12-310000055785us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-01-012022-12-310000055785us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000055785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000055785us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-12-310000055785us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-12-310000055785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-012023-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-12-310000055785us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-01-012023-12-310000055785us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000055785us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000055785us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-12-310000055785us-gaap:ParentMember2023-01-012023-12-310000055785us-gaap:ParentMember2022-01-012022-12-310000055785us-gaap:ParentMember2021-01-012021-12-310000055785kmb:UnrecognizedNetActuarialLossAndTransitionAmountMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-012023-12-310000055785kmb:UnrecognizedNetActuarialLossAndTransitionAmountMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-012022-12-310000055785kmb:UnrecognizedNetActuarialLossAndTransitionAmountMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310000055785kmb:UnrecognizedPriorServiceCostMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-012023-12-310000055785kmb:UnrecognizedPriorServiceCostMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-012022-12-310000055785kmb:UnrecognizedPriorServiceCostMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberkmb:UnrecognizedNetActuarialLossAndTransitionAmountMember2023-01-012023-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberkmb:UnrecognizedNetActuarialLossAndTransitionAmountMember2022-01-012022-12-310000055785us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberkmb:UnrecognizedNetActuarialLossAndTransitionAmountMember2021-01-012021-12-310000055785us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-12-310000055785us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-12-310000055785us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-12-310000055785us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-012021-12-310000055785kmb:CostOfProductsSoldMarketingResearchAndGeneralExpenseMember2023-01-012023-12-310000055785kmb:CostOfProductsSoldMarketingResearchAndGeneralExpenseMember2022-01-012022-12-310000055785kmb:CostOfProductsSoldMarketingResearchAndGeneralExpenseMember2021-01-012021-12-310000055785us-gaap:CostOfSalesMember2023-01-012023-12-310000055785us-gaap:CostOfSalesMember2022-01-012022-12-310000055785us-gaap:CostOfSalesMember2021-01-012021-12-310000055785us-gaap:InterestExpenseMember2023-01-012023-12-310000055785us-gaap:InterestExpenseMember2022-01-012022-12-310000055785us-gaap:InterestExpenseMember2021-01-012021-12-310000055785us-gaap:OtherNoncurrentAssetsMember2023-12-310000055785us-gaap:OtherNoncurrentAssetsMember2022-12-310000055785us-gaap:PropertyPlantAndEquipmentMember2023-12-310000055785us-gaap:PropertyPlantAndEquipmentMember2022-12-310000055785us-gaap:OtherCurrentLiabilitiesMember2023-12-310000055785us-gaap:OtherCurrentLiabilitiesMember2022-12-310000055785us-gaap:OtherNoncurrentLiabilitiesMember2023-12-310000055785us-gaap:OtherNoncurrentLiabilitiesMember2022-12-310000055785us-gaap:LongTermDebtMember2023-12-310000055785us-gaap:LongTermDebtMember2022-12-310000055785us-gaap:OtherLiabilitiesMember2023-12-310000055785us-gaap:OtherLiabilitiesMember2022-12-310000055785us-gaap:FairValueHedgingMemberus-gaap:InterestRateContractMember2023-12-310000055785us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-12-310000055785us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2023-12-310000055785us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-01-012023-12-310000055785us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-01-012022-12-310000055785us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-01-012021-12-310000055785us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-12-310000055785kmb:U.S.TaxCutsandJobsActMember2023-12-310000055785srt:MinimumMembercountry:USus-gaap:DomesticCountryMember2023-01-012023-12-310000055785country:USus-gaap:DomesticCountryMembersrt:MaximumMember2023-01-012023-12-310000055785srt:MinimumMemberus-gaap:ForeignCountryMembercountry:GB2023-01-012023-12-310000055785srt:MaximumMemberus-gaap:ForeignCountryMembercountry:GB2023-01-012023-12-310000055785country:BRsrt:MinimumMemberus-gaap:ForeignCountryMember2023-01-012023-12-310000055785country:BRsrt:MaximumMemberus-gaap:ForeignCountryMember2023-01-012023-12-310000055785srt:MinimumMembercountry:CNus-gaap:ForeignCountryMember2023-01-012023-12-310000055785country:CNsrt:MaximumMemberus-gaap:ForeignCountryMember2023-01-012023-12-310000055785srt:MinimumMembercurrency:KRWus-gaap:ForeignCountryMember2023-01-012023-12-310000055785currency:KRWsrt:MaximumMemberus-gaap:ForeignCountryMember2023-01-012023-12-310000055785kmb:BrazilTaxMatterMember2023-12-310000055785kmb:WalmartInc.MemberMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesMember2023-01-012023-12-310000055785kmb:WalmartInc.MemberMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesMember2021-01-012021-12-310000055785kmb:PersonalCareMember2021-01-012021-12-310000055785kmb:ConsumerTissueMember2021-01-012021-12-310000055785kmb:KCProfessionalMember2021-01-012021-12-310000055785us-gaap:CorporateAndOtherMember2023-01-012023-12-310000055785us-gaap:CorporateAndOtherMember2022-01-012022-12-310000055785us-gaap:CorporateAndOtherMember2021-01-012021-12-310000055785country:US2023-01-012023-12-310000055785country:US2022-01-012022-12-310000055785country:US2021-01-012021-12-310000055785us-gaap:CorporateAndOtherMemberkmb:A2018GlobalRestructuringProgramMember2021-01-012021-12-310000055785kmb:PersonalCareMemberkmb:A2018GlobalRestructuringProgramMember2021-01-012021-12-310000055785kmb:ConsumerTissueMemberkmb:A2018GlobalRestructuringProgramMember2021-01-012021-12-310000055785kmb:A2018GlobalRestructuringProgramMemberkmb:KCProfessionalMember2021-01-012021-12-310000055785us-gaap:CorporateAndOtherMember2023-12-310000055785us-gaap:CorporateAndOtherMember2022-12-310000055785us-gaap:CorporateAndOtherMember2021-12-310000055785kmb:BabyandchildcareproductsMember2023-01-012023-12-310000055785kmb:BabyandchildcareproductsMember2022-01-012022-12-310000055785kmb:BabyandchildcareproductsMember2021-01-012021-12-310000055785kmb:ConsumerTissueProductsMember2023-01-012023-12-310000055785kmb:ConsumerTissueProductsMember2022-01-012022-12-310000055785kmb:ConsumerTissueProductsMember2021-01-012021-12-310000055785kmb:AwayFromHomeProfessionalProductsMember2023-01-012023-12-310000055785kmb:AwayFromHomeProfessionalProductsMember2022-01-012022-12-310000055785kmb:AwayFromHomeProfessionalProductsMember2021-01-012021-12-310000055785kmb:AllOtherMember2023-01-012023-12-310000055785kmb:AllOtherMember2022-01-012022-12-310000055785kmb:AllOtherMember2021-01-012021-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationNetSalesMember2023-01-012023-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationGrossProfitMember2023-01-012023-12-310000055785kmb:EquityMethodInvestmentsSummarizedFinancialInformationNetIncomeMember2023-01-012023-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationNetSalesMember2022-01-012022-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationGrossProfitMember2022-01-012022-12-310000055785kmb:EquityMethodInvestmentsSummarizedFinancialInformationNetIncomeMember2022-01-012022-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationNetSalesMember2021-01-012021-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationGrossProfitMember2021-01-012021-12-310000055785kmb:EquityMethodInvestmentsSummarizedFinancialInformationNetIncomeMember2021-01-012021-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationCurrentAssetsMember2023-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssetsMember2023-12-310000055785kmb:EquityMethodInvestmentsSummarizedFinancialInformationCurrentLiabilitiesMember2023-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilitiesMember2023-12-310000055785kmb:EquityMethodInvestmentsSummarizedFinancialInformationStockholdersEquityMember2023-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationCurrentAssetsMember2022-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssetsMember2022-12-310000055785kmb:EquityMethodInvestmentsSummarizedFinancialInformationCurrentLiabilitiesMember2022-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilitiesMember2022-12-310000055785kmb:EquityMethodInvestmentsSummarizedFinancialInformationStockholdersEquityMember2022-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationCurrentAssetsMember2021-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssetsMember2021-12-310000055785kmb:EquityMethodInvestmentsSummarizedFinancialInformationCurrentLiabilitiesMember2021-12-310000055785kmb:EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilitiesMember2021-12-310000055785kmb:EquityMethodInvestmentsSummarizedFinancialInformationStockholdersEquityMember2021-12-310000055785kmb:KimberlyClarkDeMexicoSABDeCVAndSubsidiariesMember2023-12-310000055785us-gaap:AccountsReceivableMember2023-01-012023-12-310000055785kmb:LifoMember2023-12-310000055785kmb:NonLifoMember2023-12-310000055785kmb:LifoMember2022-12-310000055785kmb:NonLifoMember2022-12-310000055785country:US2023-12-310000055785country:US2022-12-310000055785us-gaap:AllowanceForCreditLossMember2022-12-310000055785us-gaap:AllowanceForCreditLossMember2023-01-012023-12-310000055785us-gaap:AllowanceForCreditLossMember2023-12-310000055785kmb:AllowancesForSalesDiscountsMember2022-12-310000055785kmb:AllowancesForSalesDiscountsMember2023-01-012023-12-310000055785kmb:AllowancesForSalesDiscountsMember2023-12-310000055785us-gaap:AllowanceForCreditLossMember2021-12-310000055785us-gaap:AllowanceForCreditLossMember2022-01-012022-12-310000055785kmb:AllowancesForSalesDiscountsMember2021-12-310000055785kmb:AllowancesForSalesDiscountsMember2022-01-012022-12-310000055785us-gaap:AllowanceForCreditLossMember2020-12-310000055785us-gaap:AllowanceForCreditLossMember2021-01-012021-12-310000055785kmb:AllowancesForSalesDiscountsMember2020-12-310000055785kmb:AllowancesForSalesDiscountsMember2021-01-012021-12-310000055785kmb:DeferredTaxesMember2022-12-310000055785kmb:DeferredTaxesMember2023-01-012023-12-310000055785kmb:DeferredTaxesMember2023-12-310000055785kmb:DeferredTaxesMember2021-12-310000055785kmb:DeferredTaxesMember2022-01-012022-12-310000055785kmb:DeferredTaxesMember2020-12-310000055785kmb:DeferredTaxesMember2021-01-012021-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
    Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the fiscal year ended December 31, 2023
    Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from                  to
Commission File Number 1-225        
kclogoa13.jpg
KIMBERLY-CLARK CORPORATION
(Exact name of registrant as specified in its charter)
Delaware39-0394230
(State or other jurisdiction of incorporation)(I.R.S. Employer Identification No.)
P.O. Box 619100
Dallas, TX
75261-9100
(Address of principal executive offices)
(Zip code)
Registrant's telephone number, including area code: (972) 281-1200
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock-$1.25 par valueKMBNew York Stock Exchange
0.625% Notes due 2024KMB24New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes        No    
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes        No    
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes        No    
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
  Accelerated filerEmerging growth company
Non-accelerated filer  Smaller reporting company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).           Yes      No  
The aggregate market value of the registrant's common stock held by non-affiliates on June 30, 2023 (based on closing stock price on the New York Stock Exchange as of such date) was approximately $46.7 billion.
As of January 31, 2024, there were 336,883,198 shares of Kimberly-Clark common stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Certain information contained in the definitive Proxy Statement for Kimberly-Clark's Annual Meeting of Stockholders to be held on May 2, 2024 is incorporated by reference into Part III.



KIMBERLY-CLARK CORPORATION
TABLE OF CONTENTS
 
Page
Part I
Item 1.
Item 1A.
Item 1B.
Item 1C.
Item 2.
Item 3.
Item 4.
Part II
Item 5.
Item 6.
Item 7.
Item 7A.
Item 8.
Item 9.
Item 9A.
Item 9B.
Item 9C.
 71
Part III
Item 10.
Item 11.
Item 12.
Item 13.
Item 14.
Part IV
Item 15.
Item 16.

 
 

KIMBERLY-CLARK CORPORATION - 2023 Annual Report

PART I

ITEM 1.    BUSINESS
Kimberly-Clark Corporation was founded in 1872 and incorporated in Delaware in 1928. We are a global company focused on delivering products and solutions that provide better care for a better world through product innovation and building our personal care, consumer tissue and K-C Professional brands. We are principally engaged in the manufacturing and marketing of a wide range of products made from natural or synthetic fibers and materials using advanced technologies in fibers, nonwovens and absorbency. Unless the context indicates otherwise, the terms "Corporation," "Kimberly-Clark," "K-C," "we," "our" and "us" refer to Kimberly-Clark Corporation and its consolidated subsidiaries.
Dollar amounts are reported in millions, except per share dollar amounts, unless otherwise noted.
Description of Kimberly-Clark
We are organized into operating segments based on product groupings. These operating segments have been aggregated into three reportable global business segments as follows:
Personal Care brands offer our consumers a trusted partner in caring for themselves and their families by delivering confidence, protection and discretion through a wide variety of innovative solutions and products such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear and other related products.  Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex and other brand names.
Consumer Tissue offers a wide variety of innovative solutions and trusted brands that responsibly improve everyday living for families around the world.  Products in this segment include facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Andrex, Viva, Scottex and other brand names.
K-C Professional partners with businesses to create Exceptional Workplaces, helping to make them healthier, safer and more productive through a range of solutions and supporting products such as wipers, tissue, towels, personal protective equipment, soaps and sanitizers. Our brands, including Kleenex, Scott, WypAll, Kimtech and KleenGuard are well known for quality and trusted to help people around the world work better.
These reportable segments were determined in accordance with how our chief operating decision maker and our executive managers develop and execute our global strategies to drive growth and profitability of our Personal Care, Consumer Tissue and K-C Professional operations. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management and capacity, and capital investments for each of these businesses.
Products for household use are sold directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores and other retail outlets, as well as through other distributors and e-commerce. Products for away-from-home use are sold through distributors, directly to manufacturing, lodging, office building, food service, and high-volume public facilities, and through e-commerce.
Our largest customer, Walmart Inc., represented approximately 13 percent in 2023 and 2022 and 14 percent in 2021 of our consolidated net sales. Net sales to Walmart Inc. were primarily in the Personal Care and Consumer Tissue segments.
On February 24, 2022, we completed our acquisition of a majority and controlling share of Thinx Inc. (“Thinx”), an industry leader in the reusable period and incontinence underwear category, for total consideration of $181 consisting of cash of $53, the fair value of our previously held equity investment of $127, and certain share-based award costs of $1. In the first quarter of 2023, we delivered a redemption notice to the third-party minority owner with respect to a portion of the remaining common securities of Thinx. This redemption closed in the second quarter of 2023, and we acquired additional ownership of Thinx for $48, increasing our ownership in Thinx to 70 percent. As part of the completion of a negotiated final redemption, we acquired the remaining 30 percent ownership of Thinx for $47 in the fourth quarter of 2023. See Item 8, Note 3 to the consolidated financial statements for details.

1
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


On June 1, 2023, we completed the sale transaction, announced on October 24, 2022, of our Neve tissue brand and related consumer and K-C Professional tissue assets in Brazil for $212, including the base purchase price of $175 and working capital and other closing adjustments of $37. This transaction also included a licensing agreement to allow the acquirer to manufacture and market in Brazil the Kleenex, Scott and Wypall brands to consumers and away-from-home customers for a period of time. See Item 8, Note 3 to the consolidated financial statements for details.
Patents and Trademarks
We own various patents and trademarks registered domestically and in many foreign countries. We consider the patents and trademarks that we own and the trademarks under which we sell certain of our products to be material to our business. Consequently, we seek patent and trademark protection by all available means, including registration.
Raw Materials
Cellulose fiber, in the form of kraft pulp or fiber recycled from recovered waste paper, is the primary raw material for our tissue products, and in the form of fluff pulp, is a component of disposable diapers, training and youth pants, feminine pads and incontinence care products.
Polypropylene and other synthetics and chemicals are the primary raw materials for manufacturing nonwoven fabrics, which are used in disposable diapers, training and youth pants, wet wipes, feminine pads, incontinence care products, and away-from-home wipers and apparel. Superabsorbent materials are important components of disposable diapers, training and youth pants and incontinence care products.
Raw materials are purchased from third parties, and we consider the supply to be adequate to meet the needs of our businesses. See Item 1A, "Risk Factors."
Competition
We have several major competitors in most of our markets, some of which are larger and more diversified than us. The principal methods and elements of competition include brand recognition and loyalty, product innovation, quality and performance, price, and marketing and distribution capabilities. For additional discussion of the competitive environment in which we conduct our business, see Item 1A, "Risk Factors."
Foreign Market Risks
We operate and market our products globally, and our business strategy includes targeted growth in Latin America, Asia, the Middle East and Africa. See Item 1A, "Risk Factors" for a discussion of foreign market risks that may affect our financial results.
Corporate Responsibility and Sustainability
Better care for a better world begins with focusing on the health and safety of our customers, consumers, and employees; promoting the value of inclusion, equity and diversity within our business; and making efforts to protect the rights of workers across our supply chain. We believe we can make meaningful contributions through our business activities and operations to clean water and sanitation, climate action and responsible consumption and production. Our sustainability strategy puts our brand, supply chain and innovation teams to work with the goal of creating shared value by addressing relevant global challenges and is focused on addressing key climate-related risks and opportunities throughout our value chain.
We strive to make lives better while also working to help safeguard the earth’s natural systems. We implement this effort by considering our sustainability goals during our business and capital planning processes, coordinating the priorities of our supply chain, brand and innovation teams, and establishing meaningful performance indicators. Our environmental priorities include reducing our use of new fossil fuel-based plastic, while enabling circular systems to recover the materials in our products and packaging; reducing our products’ use of natural forest fiber, while supporting forest biodiversity and forest dependent communities; reducing greenhouse gas emissions along our value chain, with goals approved by the Science Based Targets initiative ("SBTi"); and building resilience to water risk at our facilities and in our communities in water-stressed regions around the world. We have aligned our goals with the United Nations' Sustainable Development Goals framework. Progress on our strategy is outlined in our Global Sustainability reports.

2
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


For 2024 and 2025, we expect total capital expenditures for voluntary environmental controls or controls necessary to comply with legal requirements relating to the protection of the environment at our facilities to average approximately $50 on an annual basis. Total operating expenses for environmental compliance, including pollution control equipment operation and maintenance costs, governmental fees, and research and engineering costs, are expected to be approximately $100 in 2024 and $110 in 2025.
Total environmental capital expenditures and operating expenses are not expected to have a material effect on our total capital and operating expenditures, consolidated earnings or competitive position. Current environmental spending estimates could be modified as a result of changes in our plans or changes in legal requirements, including any requirements related to global climate change or other factors.
Regulatory Compliance
We are subject to many laws and regulations across all the countries in which we do business, and we are particularly impacted by those relating to product safety, environmental protection and data privacy and protection. We are also subject to anti-corruption laws and regulations, such as the U.S. Foreign Corrupt Practices Act, and antitrust and competition laws and regulations that govern our dealings with suppliers, customers, competitors and government officials.
We are obligated to comply with regulations that cover product safety, efficacy, manufacturing, advertising, labeling and safety reporting. These include requirements that we provide a label that highlights perceived concerns about a product or warns consumers of risks of using our products. In some cases, it may be necessary to initiate product recalls if safety risks are considered to exist. All our facilities and other operations are subject to various environmental protection statutes and regulations, including those relating to the use of water resources and the discharge of wastewater. We are also subject to expanding laws and regulations related to sustainability-related matters, non-financial reporting and diligence, labor and employment, trade, taxation and data privacy and protection, including the European Union’s General Data Protection Regulation, Brazil's General Data Protection Law, China's Personal Information Protection Law, and the California Consumer Privacy Act of 2018.
Our policy is to abide by all applicable laws and regulations, and we have internal programs in place to manage global compliance with these various requirements. We also expect that our many suppliers, consultants and other third parties working on our behalf share our commitment to compliance, and we have policies and procedures in place to manage these relationships, though they inherently involve a lesser degree of control over operations and governance. We monitor each of these areas for new or changed regulatory requirements, particularly in the rapidly evolving area of data privacy and protection. We have made, and plan to continue making, necessary expenditures for compliance with applicable laws and regulations; however, total capital expenditures and operating expenses related to compliance are not expected to have a material effect on our total capital and operating expenditures, consolidated earnings or competitive position.
Human Capital Management
We had approximately 41,000 employees as of December 31, 2023 in our consolidated operations. Approximately 35 percent of our employees were located in North America and the remainder were in approximately 60 countries outside of North America. Overall, approximately 55 percent of our workforce was directly involved in manufacturing and distribution operations.
In order to recruit, retain, develop, protect and fairly compensate our employees, we focus on the following four key areas:
Inclusion, equity and diversity – We believe our business success is tied to creating workplaces, communities and experiences where inclusion, equity and diversity are evident and thriving. We prioritize the need to cultivate a workforce where our employees are included and empowered to do their best work. Employing people from disparate backgrounds, cultures, and experiences amplifies our ability to gather insights, foster innovation and understand the culture, context, and mindset of consumers around the world. As a company who serves global consumers and communities, we work to cultivate a workforce comprised of people who look, think, and behave like the people who use our products – now and in the future. As such, we support workforce inclusion, equity and diversity and consider it a fundamental business strategy. The Management Development and Compensation Committee (“MDC”) of the Board of Directors is responsible for reviewing our inclusion, equity and diversity strategy.

3
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Health and safety – We strive to protect the health and safety of our employees. We create and administer company-wide policies and processes designed to protect our employees and to comply with applicable safety regulations. Health and safety training is regularly provided to our employees. We review and monitor our performance closely to drive continuous improvement in our safety programs.
Development and employee engagement – Developing talent and leaders at all levels of the organization and engaging our employees is critical to our long-term success. We maintain talent and succession planning processes and have leadership and management development programs as well as broad learning opportunities to support career growth and skill advancement.
We also offer all employees the opportunity to join any of our Employee Resource Groups ("ERGs"). These groups foster professional development, social connectivity, and celebrate diversity throughout our company. Current ERGs provide community and insights into the perspectives and experiences of those with African, Hispanic, Latino, and Asian ancestry, women, and LGBTQ+, as well as parents, caregivers, people with disabilities, military veterans, and new employees. Our ERGs promote career development by allowing employees to connect with and learn from one another and help amplify our inclusion, equity and diversity efforts.
In regard to employee engagement, we hold regular Town Hall meetings where employees can ask questions of executives and make their voice heard. We host a series of conversations to drive employee and leadership engagement across a variety of topics on inclusion. We engage in continuous listening via global surveys, on an ongoing basis, that offer our employees the ability to provide feedback and valuable insights to help address potential issues and identify opportunities to improve and support employee engagement.
Compensation and benefits – We provide market-based competitive compensation through our salary, annual incentive and long-term incentive programs and robust benefits packages that promote employee well-being across all aspects of their lives. Eligible employees are compensated for their contributions to our goals with both short-term cash incentives and long-term equity-based incentives. We also provide a variety of resources and services to help our employees plan for retirement. We believe the structure of our compensation packages provides the appropriate incentives to attract, retain and motivate our employees.
The MDC is responsible for establishing and administering the policies governing annual compensation and long-term compensation to ensure that the policies are designed to align compensation with our overall business strategy and performance.
Available Information
We make financial information, news releases and other information available on our corporate website at www.kimberly-clark.com. Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 are available free of charge on this website as soon as reasonably practicable after we file these reports and amendments with, or furnish them to, the Securities and Exchange Commission ("SEC"). The information contained on or connected to our website is not incorporated by reference into this Annual Report on Form 10-K and should not be considered part of this or any other report filed with the SEC. Stockholders may also contact Stockholder Services, P.O. Box 612606, Dallas, Texas 75261-2606 to obtain a hard copy of these reports without charge.
ITEM 1A.    RISK FACTORS
Our business faces many risks and uncertainties that we cannot control. Any of the risks discussed below, as well as factors described in other places in this Form 10-K, or in our other filings with the SEC, could adversely affect our business, consolidated financial position, results of operations or cash flows. In addition, these items could cause our future results to differ from those in any of our forward-looking statements. These risks are not the only ones we face. Other risks that we do not presently know about or that we presently believe are not material could also adversely affect us.

4
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Business Operations
Significant increases in prices for raw materials, energy, transportation or other necessary supplies or services, without corresponding increases in our selling prices, could adversely affect our financial results.
Increases in the cost and availability of raw materials, including pulp and petroleum-based materials, the cost of energy, transportation and other necessary services, supplier constraints, supplier consolidation which could limit our sources of supply for these items, an inability to maintain favorable supplier arrangements and relations or an inability to avoid disruptions in production output could have an adverse effect on our financial results.
Cellulose fiber, in the form of kraft pulp or recycled fiber from recovered waste paper, is used extensively in our tissue products and is subject to significant price fluctuations. Cellulose fiber, in the form of fluff pulp, is a key component in our personal care products. In past years, pulp prices have experienced significant volatility. Increases in pulp prices or limits in the availability of recycled fiber could adversely affect our earnings if selling prices for our finished products are not adjusted or if these adjustments significantly trail the increases in pulp prices. We utilize a variety of pricing structures and revenue growth management strategies to manage these risks but have not used derivative instruments.
A number of our products, such as diapers, training and youth pants, feminine pads, incontinence care products and disposable wipes, contain certain materials that are principally derived from petroleum. These materials are subject to price fluctuations based on changes in petroleum prices, availability and other factors, with these prices experiencing significant volatility in recent years. We purchase these materials from a number of suppliers. Significant increases in prices for these materials could adversely affect our earnings if selling prices for our finished products are not adjusted, if these adjustments significantly trail the increases in prices for these materials, or if we do not utilize lower priced substitutes for these materials.
Our manufacturing operations utilize electricity, natural gas and petroleum-based fuels. To help ensure we use energy efficiently and cost-effectively, we maintain energy efficiency improvement programs at our manufacturing sites. Our contracts with energy suppliers vary as to price, payment terms, quantities and duration. Our energy costs are also affected by various market factors including the availability of supplies of particular forms of energy, energy prices and local and national regulatory decisions (including actions taken to address climate change and related market responses) and geopolitical factors. There can be no assurance that we will be fully protected against substantial changes in the price or availability of energy sources.
There can be no assurance that our efforts to minimize the impact of increased costs, including increasing selling prices, in response to the increased costs will be successful.
Failure of key technology systems, cyberattacks, privacy breaches or data breaches could have a material adverse effect on our business, financial condition, results of operations and reputation.
To conduct our business, we rely extensively on information and operational technology systems, many of which are managed, hosted, provided and/or used by third parties and their vendors. These systems include, but are not limited to, programs and processes relating to internal communications and communicating with customers, consumers, vendors, investors and other parties; ordering and managing materials from suppliers; converting materials to finished products; receiving and processing purchase orders and shipping products to customers; processing transactions; storing, processing and transmitting data, including personal confidential information and payment card industry data; supporting employee data processing for our global workforce; hosting, processing and sharing confidential and proprietary research, business and financial information; and complying with financial reporting, regulatory, legal and tax requirements. Furthermore, we sell certain products directly to consumers online and through websites, mobile apps and connected devices, and we also engage in online activities, including data collection, promotions, rebates and customer loyalty and other programs, through which we may receive personal information. A breach or other breakdown in our technology, including a cyberattack, privacy incident, data incident or other event involving us or any of our third-party service providers or vendors could adversely affect our financial condition and results of operations.
Despite the security measures we have in place, the information and operational technology systems, including those of our customers, vendors, suppliers and other third-party service providers with whom we have contracted, have, in the past, and may, in the future, be vulnerable to cyber-threats such as computer viruses or other malicious codes, ransomware, cyber extortion, security incidents, denial of service attacks, unauthorized access, phishing attacks, social engineering and other disruptions from employee error, unauthorized uses, system failures, including Internet outages, unintentional or malicious actions of employees or contractors or cyberattacks by hackers, criminal groups, nation-states and nation-state-sponsored

5
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


organizations and social-activist organizations. We have seen and may continue to see an increase in the number of such attacks, especially as we continue operating under a hybrid working model under which employees can work and access our technology infrastructure remotely. In addition, while we have purchased cybersecurity insurance, costs related to a cyberattack may exceed the amount of insurance coverage or be excluded under the terms of our cybersecurity insurance policy. As cyberattacks increase in frequency and magnitude, we may be unable to obtain cybersecurity insurance in amounts and on terms we view as appropriate for our operations.
Our security efforts and the efforts of our third-party providers may not prevent or timely detect future attacks and resulting breaches or breakdowns of our, or third-party service providers’, databases or systems. In addition, if we or our third-party providers are unable to effectively resolve such breaches or breakdowns on a timely basis, we may experience interruptions in our ability to manage or conduct business, as well as reputational harm, governmental fines, penalties, regulatory proceedings, and litigation and remediation expenses. In addition, such incidents could result in unauthorized disclosure and misuse of material confidential information, including personal identifying information.
Cyber-threats are becoming more sophisticated, are constantly evolving and are being made by groups and individuals with a wide range of expertise and motives, and this increases the difficulty of detecting and successfully defending against them. We have incurred, and will continue to incur, expenses to comply with privacy and data protection standards and protocols imposed by law, regulation, industry standards and contractual obligations. Increased regulation of data collection, use, and retention practices, including self-regulation and industry standards, changes in existing laws and regulations, including reporting requirements, enactment of new laws and regulations, increased enforcement activity, and changes in interpretation of laws, could increase our cost of compliance and operation, limit our ability to grow our business or otherwise harm our business.
In addition, data incidents or theft of personal information collected by us and our third-party service providers as well as data incidents or theft of our information may occur. We are subject to the laws and regulations of various countries where we operate or do business related to solicitation, collection, processing, transferring, storing or use of consumer, customer, vendor or employee information or related data. These laws and regulations change frequently, and new legislation continues to be introduced and may be interpreted and applied differently from jurisdiction to jurisdiction and may create inconsistent or conflicting requirements. The changes introduced by data privacy and protection regulations increase the complexity of regulations enacted to protect business and personal data and they subject us to additional costs. These laws and regulations also may result in us incurring additional expenses and liabilities in the event of unauthorized access to or disclosure of personal data.
We are in the process of upgrading our enterprise resource planning system (known as SAP) to enhance operating efficiencies and provide more effective management of our business operations. We also use various other hardware, software and operating systems that may need to be upgraded or replaced in the near future as such systems cease to be supported by third-party service providers, and may be vulnerable to increased risks, including the risk of security breaches, system failures and disruptions. System upgrades take time, require oversight and may be costly, and pose several challenges, including training of personnel, communication of new rules and procedures, migration of data, increased risk of security breaches, and the potential instability of the new system. Moreover, there is no assurance that the new enterprise resource planning system will meet our current and future business needs or that it will operate as designed. Any significant failure or delay in system upgrades could cause an interruption to our business and adversely affect our operations and financial results.
Our international operations are subject to foreign market risks, including changes in foreign currency exchange rates, currency restrictions and political, social and economic instability, which may adversely affect our financial results.
Our strategy includes operations growth outside the U.S., especially in developing markets such as China, Eastern Europe, ASEAN and Latin America. About half of our net sales come from markets outside the U.S. We and our equity companies have manufacturing facilities in 33 countries and sell products in a substantial majority of countries around the world. Our results may be adversely affected by a number of foreign market risks:
Exposure to the movement of various currencies against each other and the U.S. dollar. A portion of the exposures, arising from transactions and commitments denominated in non-local currencies, is systematically managed through foreign currency forward and swap contracts where available and economically advantageous. We do not generally hedge our income statement translation exposure with respect to foreign operations.
Increases in currency exchange restrictions. These restrictions could limit our ability to repatriate earnings from outside the U.S. or obtain currency exchange for U.S. dollar inputs to continue operating in certain countries.

6
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Adverse political conditions. Risks related to political instabilities and hostilities (including the wars in Ukraine and Israel), expropriation, new or revised legal or regulatory constraints, difficulties in enforcing contractual and intellectual property rights, and potentially adverse tax consequences could adversely affect our financial results.
Increases in dollar-based input costs for operations outside the U.S. due to weaker foreign exchange rates versus the U.S. dollar. There can be no assurance that we will be protected against substantial foreign currency fluctuations.
Greater economic volatility and vulnerability to infrastructure and labor disruptions.
The inability to effectively manage foreign market risk could adversely affect our business, consolidated financial condition, results of operations or liquidity. See Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") and Item 8, Note 1 to the consolidated financial statements for information regarding our adoption of highly inflationary accounting in Argentina and Türkiye.
Our operations in Russia and the surrounding region are impacted by the war in Ukraine.
The war between Russia and Ukraine has negatively impacted, and may continue to negatively impact, our operations in Russia and the surrounding region. Beginning in March 2022, we have implemented significant adjustments to our business in Russia. We have substantially curtailed media, advertising and promotional activity and suspended capital investments at our single manufacturing facility in Russia. Consistent with the humanitarian nature of our products, we manufacture and sell only essential items in Russia, such as baby diapers and feminine pads, which are critical to the health and hygiene of women, girls and babies. Our ability to continue our reduced operations in Russia may change as we continue to experience increased input costs, supply chain complexities, reduced consumer demand, restricted access to raw materials and production assets, restricted access to financial institutions and increased supply chain, professional services, monetary, currency, trade and payment/investment sanctions and related controls. As the business, geopolitical, and regulatory environment concerning Russia evolves, we may not be able to sustain the limited manufacture and sale of our products, and our assets may be partially or fully impaired. Moreover, the war in Ukraine could result in cyber-based attacks to our information technology systems, disruptions to foreign exchange rates and financial and credit markets and amplify or affect the other risk factors set forth in this Part I, Item 1A, any of which may adversely affect our business.
We face various risks related to health epidemics, pandemics and similar outbreaks, which may have material adverse effects on our business, financial position, results of operations and cash flows.
Our business and financial results may be negatively impacted by health epidemics, pandemics and similar outbreaks. The COVID-19 pandemic has had and could continue to have negative impacts on our business, including causing significant volatility in demand for our products, changes in consumer behavior and preference, disruptions in our manufacturing and supply chain operations, disruptions to our cost saving programs, limitations on our employees’ ability to work and travel, significant changes in the economic or political conditions in markets in which we operate and related currency and commodity volatility. Despite our efforts to manage these impacts, their ultimate impact also depends on factors beyond our knowledge or control, including the duration and severity of any such outbreak and actions taken to contain its spread and mitigate its public health effects.
Damage to the reputation of Kimberly-Clark or to one or more of our brands could adversely affect our business.
Developing and maintaining our reputation, as well as the reputation of our brands, is a critical factor in our relationship with consumers, customers, suppliers and others. Our inability to address adverse publicity or other issues, including with respect to product safety, quality, efficacy, environmental impacts (including packaging, energy and water use and waste management), substances and ingredients of potential concern, inclusion, equity and diversity, human rights and other social responsibility or similar matters, or breaches of consumer, customer, supplier, employee or other confidential information, real or perceived, could negatively impact sentiment towards us and our products and brands, and our business and financial results could suffer. In addition, our products could face withdrawal, recall or other quality issues. Consumers increasing use and reliance on social media for information could increase the risk of adverse publicity, potentially with negative perception of our products or brands. Our business and results could also be negatively impacted by the effects of product-related litigation, allegations of product tampering or contamination, or the distribution and sale of counterfeit products.
Disruption in our supply chain or our manufacturing or distribution operations could adversely affect our business.
Our ability to manufacture, distribute and sell products is critical to our operations. These activities are subject to inherent risks such as natural disasters, power outages, fires or explosions, labor strikes or labor shortages, terrorism, epidemics, pandemics

7
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


(including the COVID-19 pandemic), import restrictions, regional economic, business, environmental or political events (including the wars in Ukraine and Israel), governmental regulatory requirements or nongovernmental voluntary actions in response to global climate change or other concerns regarding the sustainability of our business, which could disrupt our supply chain and impair our ability to manufacture or sell our products. This interruption, if not mitigated in advance or otherwise effectively managed, could adversely impact our business, financial condition and results of operations, as well as require additional resources to address.
We have a complex network of suppliers, including a number of sole-source and single-source suppliers for certain commodities and raw material inputs. In addition, third parties manufacture some of our products and provide certain administrative services. Disruptions or delays at these suppliers, third-party manufacturers or service providers due to the reasons above or the failure of these parties, manufacturers or service providers to otherwise satisfactorily perform, could adversely impact our operations, sales, payments to our suppliers, employees, and others, and our ability to report financial and management information on a timely and accurate basis. In the case of our sole-source suppliers, failure to successfully negotiate satisfactory purchase terms could adversely impact our business.
There is no guarantee that our ongoing efforts to reduce costs will be successful.
We continue to implement plans to improve our competitive position by achieving cost reductions in our operations. In addition, we expect ongoing cost savings from our continuous improvement activities. We anticipate these cost savings will result from reducing material costs and manufacturing waste and realizing productivity gains, distribution efficiencies and overhead reductions in each of our business segments and in our corporate functions. Any negative impact these plans have on our relationships with employees, suppliers or customers or any failure to generate the anticipated efficiencies and savings could adversely affect our financial results.
We may acquire or divest product lines or businesses, which could impact our results.
We may pursue acquisitions of product lines or businesses from third parties. Acquisitions involve numerous risks, including difficulties in the assimilation of the operations, technologies, services and products of the acquired product lines or businesses, estimation and assumption of liabilities and contingencies, personnel turnover and the diversion of management's attention from other business concerns. We may be unable to successfully integrate and manage product lines or businesses that we may acquire in the future, or be unable to achieve anticipated benefits or cost savings from acquisitions in the timeframe we anticipate, or at all.
We may periodically divest product lines or businesses. These divestitures may adversely impact our results if we are unable to offset the dilutive impacts from the loss of revenue associated with the divested products or businesses, or mitigate overhead costs allocated to those businesses. Furthermore, the divestitures could adversely affect our ongoing business operations, including by enhancing our competitors' positions or reducing consumer confidence in our ongoing brands and products.
The inability to effectively and efficiently manage acquisitions and divestitures with the results we expect or in the timeframe we anticipate could adversely affect our business, consolidated financial condition, results of operations or liquidity.
Disruptions in the credit markets or changes to our credit ratings may adversely affect our business.
We access the long-term and short-term capital markets to obtain financing. Our financial performance, our short- and long-term debt credit ratings, interest rates, the stability of financial institutions with which we partner, geopolitical or national political developments, the stability and liquidity of the overall global capital markets and the state of the global economy, could affect our access to, and the availability and cost of, financing on acceptable terms and conditions and our ability to pay dividends in the future.
We regularly access the commercial paper market for ongoing funding requirements. A downgrade in our credit ratings by a credit rating agency could increase our borrowing costs and adversely affect our ability to issue commercial paper. Disruptions in the commercial paper market or other effects of volatile economic conditions on the credit markets also could reduce the amount of commercial paper that we could issue and raise our borrowing costs for both short- and long-term debt offerings.
Disruptions in the credit markets, limitations on our ability to borrow, a reduction in our liquidity or an increase in our borrowing costs could materially and adversely affect our financial condition and results of operations.

8
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Climate change and other sustainability matters may adversely affect our business and operations.
There is growing concern that carbon dioxide and other greenhouse gases in the atmosphere may have an adverse impact on global temperatures, weather patterns, water availability and quality, and the frequency and severity of extreme weather and natural disasters. We have transition risks related to the transition to a lower-carbon economy and physical risks related to the physical impacts of climate change. Transition risks include increased costs of carbon emission, increased cost to produce products in compliance with future regulations, increased raw materials cost, shifts in customer/consumer values and other legal, regulatory and technological risks. Physical risks include the risk of direct damage to assets or supply chain disruption caused by severe weather events such as floods, storms, wildfires and droughts. In addition, concern over climate change by governments and regulators globally have resulted and may continue to result in new legal and regulatory requirements to reduce or mitigate the effects of climate change on the environment (or conversely, to restrict activities to address or consider climate change and related matters). Compliance with these requirements may increase our costs of doing business, including to the extent these reporting regimes are inconsistent.
There is also increased focus, including by governmental and non-governmental organizations, investors and investment managers, customers, suppliers, consumers, our employees and other stakeholders on these and other sustainability matters, including responsible sourcing and deforestation, the use of plastic, energy and water, the recyclability or recoverability of packaging, including single-use and other plastic packaging and ingredient transparency. At the same time, there is growing opposition to initiatives on these matters, and our public reporting on our sustainability initiatives, expectations, and progress, including our ambitions for 2030, may not satisfy the expectations of all stakeholders. These stakeholders may rely on their assessment or perception (or a third-party’s assessment) of our sustainability practices to inform their future engagement with our company, products, and securities. Any failure to achieve our sustainability goals, including those aimed to reduce our impact on, improve or preserve the environment, or the perception (whether or not valid) that we have failed to act responsibly with respect to such matters or to effectively respond to new legal or regulatory requirements regarding climate change, could adversely affect our business and reputation, including the loss of customers or business opportunities and legal or regulatory proceedings.
Our inability to attract and retain key personnel could adversely impact our business.
We must attract, hire, retain and develop effective leaders and a highly skilled and diverse global workforce. We are experiencing an increasingly tight and competitive labor market and, should conditions worsen, we could experience greater turnover. A sustained labor shortage or increased turnover rates within our employee base could lead to increased costs over time, such as increased overtime to meet demand, and increased wages to attract and retain employees. Additionally, with our rapidly changing environment, it is critical to ensure we have the right skills, capabilities and experience needed to respond to evolving consumer and customer needs. Failure to attract and develop personnel with key emerging capabilities could disrupt our institutional knowledge base and erode our competitiveness.
Marketing and Competition
Intense competition for sales of our products, changes in consumer purchasing patterns and the inability to innovate or market our products effectively could have an adverse effect on our financial results.
We operate in highly competitive domestic and international markets against well-known, branded products and low-cost or private label products. Inherent risks in our competitive strategy include uncertainties concerning trade and consumer acceptance, the effects of consolidation within retailer and distribution channels, a growing e-commerce marketplace, and customers' and competitors' actions. Our competitors for these markets include global, regional and local manufacturers, including private label manufacturers. Some of these competitors may have better access to financial resources and greater market penetration, which enable them to offer a wider variety of products and services at more competitive prices. Alternatively, some of these competitors may have significantly lower product development and manufacturing costs, particularly with respect to private label products, allowing them to offer products at a lower price. E-commerce potentially intensifies competition by simplifying distribution and lowering barriers to entry. The actions of these competitors could adversely affect our financial results. In order to stay competitive, it may be necessary for us to lower prices on our products and increase spending on advertising and promotions, which could adversely affect our financial results.
We may be unable to anticipate or adequately respond to changes in consumer demand for our products. Demand for our products may change based on many factors, including shifting consumer purchasing patterns to lower cost options such as private-label products and mid to lower-tier value products, low birth rates in certain countries due to slow economic growth or

9
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


other factors, negative customer or consumer response to pricing actions, consumer shifts in distribution from traditional retailers to e-tailers, subscription services and direct to consumer businesses, changing consumer preferences due to increased concerns in regard to post-consumer waste and packaging materials and their impact on environmental sustainability, or other changes in consumer trends or habits. If we experience lower sales due to changes in consumer demand for our products, our earnings could decrease.
Our ability to develop new products is affected by whether we can successfully anticipate consumer needs and preferences, develop and fund technological innovations, and receive and maintain necessary patent and trademark protection. In addition, we incur substantial development and marketing costs in introducing new and improved products and technologies. The introduction of a new consumer product (whether improved or newly developed) usually requires substantial expenditures for advertising and marketing to gain recognition in the marketplace. If a product gains consumer acceptance, it normally requires continued advertising and promotional support to maintain its relative market position. Some of our competitors may spend more aggressively on advertising and promotional activities, introduce competing products more quickly and respond more effectively to changing business and economic conditions. We may not be successful in developing new or improved products and technologies necessary to compete successfully in the industry, and we may not be successful in advertising, marketing, timely launching and selling our products, including through the use of digital and social media. Also, if we fail to perfect or successfully assert our intellectual property rights, we may be less competitive, which could adversely affect our business, financial results and financial condition.
Increasing dependence on key retailers in Developed Markets and the emergence of new sales channels may adversely affect our business.
Our products are sold in a highly competitive global marketplace, which continues to experience increased concentration and the growing presence of large-format retailers, discounters and e-tailers. With the consolidation of retail trade, both traditional retailers and e-tailers, we are dependent on key customers, and some of these customers, including large-format retailers and large e-tailers, may have significant bargaining power. They may use this leverage to demand higher trade discounts or allowances which could lead to reduced profitability. We may also be negatively affected by changes in the policies of our retail trade customers, such as inventory destocking, limitations on access to shelf space, delisting of our products, additional requirements related to safety, environmental, social and other sustainability issues, and other conditions. If we lose a significant customer or if sales of our products to a significant customer materially decrease, our business, financial condition and results of operations may be adversely affected.
Legal and Regulatory
Government regulations and enforcement, and potential litigation, could have an adverse effect on our financial results.
As a global company, we are subject to a wide variety of laws and governmental regulations across all of the countries in which we do business, including laws and regulations involving marketing, antitrust, anti-bribery or anti-corruption, data privacy, product liability, product composition or formulation, packaging content or corporate responsibility after consumer purchase, environmental impact, intellectual property, employment, healthcare, tax or other matters.
We could be subject to significant legal liability and litigation expense if we fail to comply with applicable laws, regulations, policies and related interpretations. Our business is subject to the risk of litigation involving customers, consumers, suppliers, competitors, shareholders, government agencies or others through private actions, class actions, whistleblower claims, administrative proceedings, regulatory actions or other litigation. While it is our policy and practice to comply with all legal and regulatory requirements applicable to our business, we cannot provide assurance that our employees and agents will follow our policies and procedures at all times. A finding that we are in violation of, or out of compliance with, applicable laws or regulations could subject us to civil remedies, including fines, damages, injunctions, product recalls or criminal sanctions, any of which could adversely affect our business, results of operations, cash flows and financial condition. Whether or not a claim is successful, without merit or not fully pursued, negative publicity arising from allegations regarding our products, processes or business practices could adversely affect our reputation and brand image.
In addition, new or revised laws, regulations or their interpretation may alter the environment in which we do business which could adversely impact our financial results. For example, new legislation or regulations may result in increased costs to us, directly for our compliance, or indirectly to the extent suppliers increase prices of goods and services because of increased compliance costs, excise taxes or reduced availability of raw materials.

10
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


While we maintain insurance for certain potential liabilities, such insurance does not cover all types and amounts of potential liabilities and is subject to various exclusions as well as caps on amounts recoverable. Even if we believe a claim is covered by insurance, insurers may dispute our entitlement to recovery for a variety of potential reasons, which may affect the timing and, if they prevail, the amount of our recovery.
New or revised tax regulations could have an adverse effect on our financial results.
We are subject to income tax requirements in various jurisdictions in the U.S. and internationally. Tax laws are dynamic and subject to change as new laws are passed and new interpretations of the law are issued or applied. Some jurisdictions have unpredictable enforcement activity. Increases in applicable tax rates, implementation of new taxes, changes in applicable tax laws and interpretations of these tax laws and actions by tax authorities in jurisdictions in which we operate could reduce our after tax income and have an adverse effect on our results of operations.
ITEM 1B.    UNRESOLVED STAFF COMMENTS
None.
ITEM 1C.     CYBERSECURITY
Risk Management and Strategy
We have implemented a cybersecurity program to assess, identify, and manage risks from cybersecurity threats. Our efforts are designed to maintain the confidentiality, integrity, and availability of our information and operational technology systems and the data stored on those systems. The program includes:
periodic risk assessments to identify and assess cybersecurity risks and vulnerabilities in our information technology systems;
security event monitoring, management, and incident response;
third party engagements to perform periodic penetration testing and reviews of program maturity based on the National Institute of Standards and Technology ("NIST") cybersecurity framework;
reviews by our internal audit team of the effectiveness of information technology-related internal controls;
cybersecurity risk assessments of our third-party vendors; and
employee training, including regular phishing simulations.
The program is continually adapting to the evolving threat landscape and technology developments.
Cybersecurity risk management is included within our overall enterprise risk management program which is overseen by our Global Risk Oversight Committee (“GROC”). The GROC is composed of executive officers and other senior leaders and coordinates with other risk assurance functions, including internal audit and compliance. The GROC receives regular briefings concerning cybersecurity risks and risk management processes.
Additional information on cybersecurity risks we face is discussed in Item 1A, "Risk Factors,” which should be read in conjunction with the information in this section.
Internal Cybersecurity Team
Our Chief Information Security Officer (“CISO”) oversees a team with extensive cybersecurity knowledge and experience. The team is responsible for:
leading enterprise-wide cybersecurity strategy, policy, standards, architecture, and processes;
incident response and operational activities, including identifying and initiating updates to systems which require patching, vulnerability management strategy, red teaming, network security configurations and security architecture;

11
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


oversight of third parties engaged to assist in our cybersecurity risk management, along with third parties’ vendors; and
legal and regulatory compliance.
Our CISO reports to our Chief Digital and Technology Officer (“CDTO”), an executive officer, who provides management of cybersecurity risks, reviews operational metrics and performs other relevant activities related to the cybersecurity function.
Security Policy and Requirements
As part of our overall risk management program, we have adopted our Information Security Policy which details the overall risk-based framework and governance for the management and security of our information technology assets and information. The policy applies to everyone who accesses our data or information resources and all of our information systems and resources, including third parties we engage. Our program aligns with the NIST cybersecurity framework.
Material Cyber Risks, Threats and Incidents
We actively monitor the evolving cybersecurity and geopolitical landscapes that could result in new or increased cybersecurity threat including geopolitical events such as the Russia invasion of Ukraine in March 2022.
As a global company serving consumers in more than 175 countries and territories, we routinely experience a wide variety of cybersecurity incidents. However, we have not experienced a cybersecurity incident that has materially affected or is reasonably likely to materially affect our business strategy, results of operation or financial condition. For a more detailed discussion of the risks we face, see Item 1A, "Risk Factors."
Incident Response
We have adopted a cybersecurity incident response plan that is designed to provide a framework across all functions for a coordinated identification and response to security incidents. The plan specifies the process for identifying, validating, classifying, documenting, and responding to cybersecurity events as well as determining whether reporting of an event is appropriate under regulatory standards. The plan also includes a materiality assessment framework that sets forth procedures to support our assessment of whether a security incident is “material” under the federal securities laws. Internal reporting and escalation protocols are in place to ensure the involvement of the CISO, other senior leaders, and the Audit Committee, as appropriate. Under the plan, we regularly conduct tabletop exercises to test our preparedness and our incident response process, and we provide ongoing training.
Governance
Our Board of Directors has delegated to the Audit Committee oversight responsibility of our risk management program, including cybersecurity, business continuity, IT operational resilience, and data privacy. The Audit Committee receives quarterly reports from our CDTO and our CISO covering cybersecurity risks, strategic programs for managing cybersecurity risk, emerging trends and operational and policy compliance metrics.
At the management level, our cybersecurity program is led by our CDTO and our CISO. Our CDTO has served in various information technology roles for over 26 years, including as Chief Digital and Technology Officer of Kimberly-Clark and as Executive Vice President and Chief Digital Officer of Toyota Motors North America, Inc. Our CISO has served as a chief information security officer or equivalent role at large public and private companies for over 16 years. Our CISO also has several information technology-related certifications, including the Certified Information Systems Security Professional ("CISSP") certification. Our CISO reports to our CDTO, who in turn regularly reports to our Chairman of the Board and Chief Executive Officer. We have protocols by which certain cybersecurity incidents are reported promptly to the Chairman of the Board and Chief Executive Officer, or the Audit Committee, as appropriate.


12
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


ITEM 2.    PROPERTIES
As of December 31, 2023, we own or lease:
our principal executive office located in the Dallas, Texas metropolitan area;
five operating segment and geographic headquarters at three U.S. and two international locations; and
four global business service centers at one U.S. and three international locations.
The locations of our and our equity affiliates' principal production facilities by major geographic areas of the world are as follows: 
Geographic Area:
Number of
Facilities
North America (in 14 states in the U.S.)28 
Outside North America54 
Total (in 33 countries)82 
Many of these facilities produce multiple products, some across multiple segments. Consumer tissue and K-C Professional products are produced in 47 facilities and personal care products are produced in 48 facilities. We believe that our and our equity affiliates' facilities are suitable for their purpose, adequate to support their businesses and well maintained.
ITEM 3.    LEGAL PROCEEDINGS
See Item 8, Note 11 to the consolidated financial statements, which is incorporated in this Item 3 by reference, for information on legal proceedings.
ITEM 4.    MINE SAFETY DISCLOSURES
Not applicable.


13
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


INFORMATION ABOUT OUR EXECUTIVE OFFICERS
The names and ages of our executive officers as of February 8, 2024, together with certain biographical information, are as follows:
Ehab Abou-Oaf, 57, was elected President of K-C Professional in 2022. He is responsible for our global business to business operations which provide a deep range of essential commercial products and services, including tissue and surface wipers, skin care, safety and do-it-yourself products. Previously, he served as Vice President, Middle East & Africa since 2020. Mr. Abouf-Oaf joined Kimberly-Clark from Mars, Inc., a manufacturer of confectionery, pet food, and other food products, where he had a number of positions with increasing responsibility over 19 years, including Regional President, Asia, Middle East & Africa Confectionery from 2017 to 2019 and Regional President, Asia Pacific, Middle East & Northern Africa Chocolate from 2016 to 2017. Prior to joining Mars, he spent ten years with The Procter & Gamble Company in packaging, product development and marketing roles. He also serves on the board of trustees of the American University in Cairo and on the board of directors of the Singapore American School.
Doug Cunningham, 52, was elected President, K-C Europe, Middle East & Africa ("EMEA") in 2021. He is responsible for our consumer business in our EMEA region. Prior to that, he served as Vice President and Managing Director, Australia & New Zealand since 2019. Mr. Cunningham joined Kimberly-Clark from Johnson & Johnson, a health care products company, where he served in multiple roles across Asia Pacific, North America and Africa, most recently as Managing Director, Johnson & Johnson Pacific.

Tamera Fenske, 45, was elected Senior Vice President and Chief Supply Chain Officer in 2022. She is responsible for procurement, manufacturing, logistics, transportation, safety and sustainability, as well as our global nonwovens division. Ms. Fenske joined Kimberly-Clark from 3M Company where she served in multiple roles of increasing responsibility, most recently as Senior Vice President, U.S. and Canada Manufacturing and Supply Chain from February 2022 to September 2022, Senior Vice President Global Operations, Transportation & Electronics Business Group (TEBG) from 2021 to February 2022, Vice President of Global Operations, TEBG, from 2020 to 2021, Mfg/SC/LSS Vice President from 2018 to 2020, and Customer Value Stream Vice President from 2016 to 2018.
Zackery Hicks, 60, was elected Chief Digital and Technology Officer in 2022. He is responsible for all aspects of our information technology and digital functions, including building brands and creating differentiated capability. Mr. Hicks joined Kimberly-Clark from Toyota Motors North America, Inc., a subsidiary of Toyota Motor Corporation, a multinational automotive manufacturer, where he served as Executive Vice President and Chief Digital Officer since April 2018, and held roles of increasing responsibility with Toyota since 1996, including CEO and President of Toyota Connected North America. He also serves on the board of directors of Signet Jewelers Ltd.
Michael D. Hsu, 59, has served as Chairman of the Board since January 2020 and as Chief Executive Officer since January 2019. Prior to that, he served as President and Chief Operating Officer since 2017, where he was responsible for the day-to-day operations of our business units, along with our global innovation, marketing and supply chain functions. He served as Group President, K-C North America from 2013 to 2016, where he was responsible for our consumer business in North America, as well as leading the development of new business strategies for global nonwovens. From 2012 to 2013, his title was Group President, North America Consumer Products. He has been a director of Kimberly-Clark since 2017. Prior to joining Kimberly-Clark, Mr. Hsu served as Executive Vice President and Chief Commercial Officer of Kraft Foods, Inc., from January 2012 to July 2012, as President of Sales, Customer Marketing and Logistics from 2010 to 2012 and as President of its grocery business unit from 2008 to 2010. Prior to that, Mr. Hsu served as President and Chief Operating Officer, Foodservice at H. J. Heinz Company.
Sandra R.A. Karrmann, 58, was elected Senior Vice President and Chief Human Resources Officer in 2020. She is responsible for the design and implementation of all human capital strategies for Kimberly-Clark, including global compensation and benefits, talent management, inclusion, equity and diversity, organizational effectiveness and labor/employee relations. Ms. Karrmann joined Kimberly-Clark from Tenet Healthcare Corporation, a diversified healthcare services company, where she served as Executive Vice President and Chief Human Resources Officer since 2019 and Senior Vice President and Chief Human Resources Officer since 2017. Prior to joining Tenet, she served as Senior Vice President and Chief Human Resources Officer for United Surgical Partners International, which operates surgical facilities, since 2013.

14
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Alison Lewis, 56, was elected Chief Growth Officer in 2019. Ms. Lewis joined Kimberly-Clark from Johnson & Johnson, where she served as Chief Marketing Officer of the Global Consumer business since 2013. Prior to her role at Johnson & Johnson, Ms. Lewis served as Chief Marketing Officer, Senior Vice President, North America at The Coca-Cola Company.
Robert Long, 66, was elected Chief Research and Development Officer in 2021. He has global responsibility for our research and development, quality and regulatory functions, and is charged with accelerating growth through innovation that addresses opportunities to elevate Kimberly-Clark’s trusted brands. Mr. Long joined Kimberly-Clark from the Coca-Cola Company where he served in multiple roles of increasing responsibility, most recently as Senior Vice President for Global R&D and Chief Innovation Officer from 2016 to 2021.
Grant B. McGee, 43, was elected Senior Vice President and General Counsel in February 2024. Mr. McGee rejoined Kimberly-Clark from American Airlines, where he served as Vice President, Deputy General Counsel and Corporate Secretary from 2022 to February 2024. From 2015 to 2022, Mr. McGee served in various roles of increasing responsibility at Kimberly-Clark, most recently as Vice President and Senior Deputy General Counsel.
Jeffrey Melucci, 53, was elected Chief Business and Transformation Officer in January 2024. From November 2020 to January 2024, he served as Chief Business Development and Legal Officer, from April 2020 to November 2020, he served as Senior Vice President, Business Development and General Counsel and from September 2017 to April 2020, he served as Senior Vice President - General Counsel. From January 2017 to September 2017, he served as Vice President, Senior Deputy General Counsel and General Counsel of Kimberly-Clark’s Global Operations. From 2013 to 2017, he served as Vice President and Deputy General Counsel. He also served as Chief Transformation Officer from November 2020 to October 2021, Corporate Secretary from 2014 to 2017 and General Counsel of Kimberly-Clark International from 2013 to 2016. Mr. Melucci joined Kimberly-Clark from General Electric, where he served in multiple roles of increasing responsibility, most recently as General Counsel - Aviation Systems and Aviation Business Development.
Paula S. Vaz Ramos, 44, was elected Chief Strategy and Transformation Officer in October 2021. From March 2021 to October 2021 she served as Chief Strategy Officer. She has global responsibility for our enterprise strategy and transformation activities. Ms. Ramos joined Kimberly-Clark from McKinsey & Company where she served in multiple roles of increasing responsibility over 18 years, most recently as a Partner.
Russell Torres, 52, was elected Group President, K-C North America in 2021. He is responsible for our consumer business in North America. From 2020 to 2021, he served as President of K-C Professional. Mr. Torres joined Kimberly-Clark from Newell Brands Inc., a consumer goods company, where he served as Group President since 2018 and as Chief Transformation Officer from 2016 to 2018. Prior to joining Newell Brands, Mr. Torres was a partner at Bain & Company from 2013 to 2016. Prior to that, Mr. Torres served as a senior executive at Mondelēz International in its North America Business Unit from 2011 to 2013.
Nelson Urdaneta, 51, was elected Senior Vice President and Chief Financial Officer in 2022. Prior to joining Kimberly-Clark, he served as Senior Vice President, Treasurer at Mondelēz International since September 2021. Mr. Urdaneta joined Mondelēz in 2005 and served in multiple roles of increasing responsibility, including Senior Vice President, Corporate Controller and Chief Accounting Officer and Vice President Finance, Asia Pacific. Prior to joining Mondelēz, he was the Director, Financial Planning and Analysis at Ryder System, Inc.
Gonzalo Uribe, 52, was elected President, K-C Latin America in 2020. He is responsible for our consumer business in our Latin America region. From 2018 to 2020 he served as Vice President, North Latin America and from 2017 to 2018 he served as Vice President, Andean Region. Mr. Uribe joined Kimberly-Clark from Mondelēz International, where he served in multiple roles of increasing responsibility, most recently as Western Andean, Central America and Caribbean General Manager.
Tristram Wilkinson, 55, was elected President, K-C Asia Pacific in 2021. He is responsible for our consumer business in our Asia Pacific region. From 2018 to 2021, he served as President, K-C EMEA. From 2016 to 2018, he served as Vice President and Managing Director, Central & Eastern Europe. Prior to that, Mr. Wilkinson held a number of positions of increasing responsibility within our EMEA operations, including Vice President and Managing Director, United Kingdom & Ireland. Mr. Wilkinson joined Kimberly-Clark in 1995.

15
KIMBERLY-CLARK CORPORATION - 2023 Annual Report

PART II

ITEM 5.    MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Kimberly-Clark common stock is listed on the New York Stock Exchange. The ticker symbol is KMB.
Quarterly dividends have been paid continually since 1935. Dividends have been paid on or about the second business day of January, April, July and October.
As of January 31, 2024, we had 16,019 holders of record of our common stock.
For information relating to securities authorized for issuance under equity compensation plans, see Part III, Item 12 of this Form 10-K.
We repurchase shares of Kimberly-Clark common stock from time to time pursuant to publicly announced share repurchase programs. During 2023, we repurchased 1.8 million shares of our common stock at a cost of $225 through a broker in the open market.
The following table contains information for shares repurchased during the fourth quarter of 2023. None of the shares in this table were repurchased directly from any of our officers or directors.
Period (2023)
Total Number
of Shares
Purchased(a)
Average
Price Paid
Per Share
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
Maximum Number
of Shares That May
Yet Be Purchased
Under the Plans or
Programs(b)
October 1 to October 31135,225 $119.78 39,963,754 40,036,246 
November 1 12,292 119.39 39,976,046 40,000,000 
November 1 to November 30507,399 121.25 507,399 39,492,601 
December 1 to December 31396,139 121.15 903,538 39,096,462 
Total
1,051,055 
(a)Share repurchases were made pursuant to share repurchase programs authorized by our Board of Directors on November 13, 2014 (the "2014 Program") and January 22, 2021 (the "2021 Program"). The 2014 Program allowed for the repurchase of 40 million shares in an amount not to exceed $5 billion, and the 2021 Program allows for the repurchase of 40 million shares in an amount not to exceed $5 billion. Purchases on November 1 of 12,292 shares exhausted the 2014 Program's $5 billion limit and, as a result, that program has expired. All remaining purchases in the fourth quarter of 2023 were made pursuant to the 2021 Program.
(b)Includes shares under both the 2014 Program (through November 1, 2023), and the 2021 Program.

ITEM 6.    SELECTED FINANCIAL DATA
Intentionally Omitted

16
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


ITEM 7.    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Introduction
This MD&A is intended to provide investors with an understanding of our recent performance, financial condition and prospects. This discussion and analysis compares 2023 results to 2022. For a discussion that compares our 2022 results to 2021, see Management's Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of our 2022 Annual Report on Form 10-K. The reference to "N.M." indicates that the calculation is not meaningful. In addition, we provide commentary regarding organic sales growth, which describes the impact of changes in volume, product mix and net selling prices on net sales. Changes in foreign currency exchange rates, acquisitions and exited businesses also impact the year-over-year change in net sales. Revenue growth management is used to describe our capability that helps optimize our consumer value proposition and thereby maximize our brands' revenue potential with consumer-centric insights. It focuses on strategic pricing decisions, price pack architecture, managing our product mix, trade promotion activity and trading terms. Dollar amounts are reported in millions, except per share dollar amounts, unless otherwise noted.
The following will be discussed and analyzed:
Overview of Business
Overview of 2023 Results
Business Environment and Trends
Results of Operations and Related Information
Liquidity and Capital Resources
Critical Accounting Policies and Use of Estimates
New Accounting Standards
Information Concerning Forward-Looking Statements
Throughout this MD&A, we refer to financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S., or GAAP, and are therefore referred to as non-GAAP financial measures. These measures include adjusted gross and operating profit, adjusted net income, adjusted earnings per share, adjusted other (income) and expense, net, and adjusted effective tax rate. We believe these measures provide our investors with additional information about our underlying results and trends, as well as insight to some of the financial measures used to evaluate management.
Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP measures, and they should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.  There are limitations to these non-GAAP financial measures because they are not prepared in accordance with GAAP and may not be comparable to similarly titled measures of other companies due to potential differences in methods of calculation and items being excluded.  We compensate for these limitations by using these non-GAAP financial measures as a supplement to the GAAP measures and by providing reconciliations of the non-GAAP and comparable GAAP financial measures.
The non-GAAP financial measures exclude the following items for the relevant time periods as indicated in the reconciliations included later in this MD&A:
Sale of Brazil tissue and K-C Professional business - In 2023, we recognized a net benefit related to the sale of our Brazil tissue and K-C Professional business. See Item 8, Note 3 to the consolidated financial statements for details.
Impairment of intangible assets - In 2023, we recognized charges related to the impairment of certain intangible assets related to Softex Indonesia and Thinx. See Item 8, Note 4 to the consolidated financial statements for details.
Pension settlements - In 2023 and 2022, pension settlement charges were recognized related to lump-sum distributions from pension plan assets exceeding the total of annual service and interest costs resulting in a recognition of deferred actuarial losses.

17
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Acquisition of controlling interest in Thinx – In the first quarter of 2022, we increased our investment in Thinx. As a result of this transaction, a net benefit was recognized, primarily due to the non-recurring, non-cash gain recognized related to the remeasurement of the carrying value of our previously held equity investment to fair value, partially offset by transaction and integration costs. See Item 8, Note 3 to the consolidated financial statements for details.
Overview of Business
We are a global company focused on delivering products and solutions that provide better care for a better world, with manufacturing facilities in 33 countries, including our equity affiliates, and products sold in more than 175 countries and territories. Our products are sold under well-known brands such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend. We have three reportable business segments: Personal Care, Consumer Tissue and K-C Professional. These business segments are described in greater detail in Item 8, Note 15 to the consolidated financial statements.
In operating our business, we seek to:
grow our portfolio of brands through innovation, category development and commercial execution,
leverage our cost and financial discipline to fund growth and improve margins, and
allocate capital in value-creating ways.
We describe our business outside North America in two groups – Developing and Emerging Markets ("D&E") and Developed Markets. D&E Markets comprise Eastern Europe, the Middle East and Africa, Latin America and Asia-Pacific, excluding Australia and South Korea. Developed Markets consist of Western and Central Europe, Australia and South Korea.
On February 24, 2022, we completed our acquisition of a majority and controlling share of Thinx, an industry leader in the reusable period and incontinence underwear category, for total consideration of $181 consisting of cash of $53, the fair value of our previously held equity investment of $127, and certain share-based award costs of $1. In the first quarter of 2023, we delivered a redemption notice to the third-party minority owner with respect to a portion of the remaining common securities of Thinx. This redemption closed in the second quarter of 2023, and we acquired additional ownership of Thinx for $48, increasing our ownership in Thinx to 70 percent. As part of the completion of a negotiated final redemption, we acquired the remaining 30 percent ownership of Thinx for $47 in the fourth quarter of 2023. As the purchase of additional ownership in an already controlled subsidiary represents an equity transaction, no gain or loss was recognized in consolidated net income or comprehensive income. See Item 8, Note 3 to the consolidated financial statements for details.
On June 1, 2023, we completed the sale transaction, announced on October 24, 2022, of our Neve tissue brand and related consumer and K-C Professional tissue assets in Brazil for $212, including the base purchase price of $175 and working capital and other closing adjustments of $37. This transaction also included a licensing agreement to allow the acquirer to manufacture and market in Brazil the Kleenex, Scott and Wypall brands to consumers and away-from-home customers for a period of time. The assets included in the sale agreement were reclassified to Other current assets as of December 31, 2022, and upon closure of the transaction, a gain of $74 pre-tax was recognized in Other (income) and expense, net. We incurred divestiture-related costs of $30 pre-tax, which were recorded in Cost of products sold and Marketing, research and general expenses, resulting in a net benefit of $44 pre-tax ($26 after tax).
Overview of 2023 Results
Net sales of $20.4 billion increased 1 percent. Organic sales increased 5 percent, while changes in foreign currency exchange rates decreased sales by 3 percent and exited business decreased sales by 1 percent.
In North America, organic sales increased 4 percent in consumer products and increased 8 percent in K-C Professional.
Outside North America, organic sales increased 5 percent in D&E Markets and increased 4 percent in Developed Markets.
Operating Profit and Net Income Attributable to Kimberly-Clark were $2,344 and $1,764 in 2023, respectively.
Diluted earnings per share were $5.21 in 2023 compared to $5.72 in 2022. Results in 2023 include the net benefit related to the sale of the Brazil tissue and K-C Professional business of $0.08, charges related to the impairment of intangible assets of $1.36 and pension settlement charges of $0.08. Results in 2022 include a net benefit of $0.20 associated with the acquisition of Thinx, primarily due to the non-recurring, non-cash gain recognized related to the

18
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


remeasurement of the carrying value of our previously held equity investment to fair value, partially offset by transaction and integration costs, and pension settlement charges of $0.12.
We continue to focus on generating cash flow and allocating capital to shareholders. Cash provided by operations was $3.5 billion in 2023. We raised our dividend in 2023 by 2 percent, the 51st consecutive annual increase in our dividend. Altogether, share repurchases and dividends in 2023 amounted to $1.8 billion.
In 2024, we plan to continue to execute our strategies for long-term success which include delivering balanced, sustainable growth by growing our brands in-line with or ahead of category growth, leveraging our cost and financial discipline to fund growth and improve margins, and allocating capital in value-creating ways. Our growth strategy is built on two pillars. Elevate our core business is our first pillar and is driven by delivering value-added innovations and driving category opportunities. Expanding our markets is our second pillar and emphasizes Personal Care. Both strategies are enabled by our focus on accelerating and investing in our commercial capabilities through digital marketing, revenue growth management, consumer-inspired innovation and strong in-market execution.
Our strong legacy of financial discipline supports our growth strategy by driving ongoing supply chain productivity through our FORCE (Focused On Reducing Costs Everywhere) program, controlling discretionary spending, driving down working capital and maintaining the top-tier return on invested capital. Our capital allocation strategy is consistent with our historical approach of disciplined capital spending, payment of a top tier dividend, evaluation of acquisition opportunities and allocation of excess cash flow to share repurchases.
We are subject to risks and uncertainties, which can affect our business operations and financial results. See Item 1A, "Risk Factors" in this Form 10-K for additional information.
Business Environment and Trends
Our results of operations have been, and we expect them to continue to be, affected by the following factors and key trends, which may cause our future results of operations to differ from our historical results discussed under “Results of Operations and Related Information.”
COVID-19 - The macro business environment has experienced unprecedented volatility in recent years reflecting the effects of the global COVID-19 pandemic on supply and demand dynamics. We have seen stabilization in demand across all of our business segments during 2022 and 2023, and we expect this trend to continue.
The pandemic significantly disrupted supply chains across the globe, primarily due to the very significant fluctuations in demand and related transportation and labor supply issues. Resulting supply shortages led to record levels of inflation in commodities and other costs. During 2023, inflation slowed, but costs remain elevated across many categories of our raw materials, labor, energy and other input costs, as well as transportation costs, and we expect that these elevated levels could persist in 2024, although at a decreasing rate of inflation compared to the prior fiscal year.
Additionally, consumer purchasing power has generally been impacted negatively by the inflation driven by the effects of the pandemic which can impact consumer purchasing patterns.
Birth Rate Trends - Sales of our baby and child care products are highly correlated with birth rate trends. In recent years, birth rate declines in key countries, including China, South Korea and the U.S., have pressured category volume growth rates. To help mitigate the effects of birth rate declines, we aim to drive sales growth at or ahead of category growth rates through innovation, premiumization, strong brand building plans and digital marketing investment as part of our Elevate and Expand growth strategy.
Competition - Our products are sold in a highly competitive global marketplace. Our competitors include global, regional and local manufacturers, including private label manufacturers which offer products that are typically sold at lower prices. In particular, private label market share has been increasing in the tissue category. Increased purchases of private label products could reduce net sales of our higher-margin products which would negatively impact our profitability. While the global marketplace in which we operate has always been highly competitive, we continue to experience increased concentration and the growing presence of large-format retailers, discounters and e-tailers. This market environment has resulted in increased pressure on pricing and other competitive factors, and we expect these pressures to continue in the coming year.

19
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Pricing - Our net sales growth and profitability may be affected as we adjust prices to address market conditions. We adjust our product prices based on a number of variables including demand, the competitive environment, technological improvements, product innovations and changes in our raw material, distribution, energy and other input costs. In 2022 and early 2023, certain price increases were in response to continuing inflation related to the ongoing impacts of the COVID-19 pandemic and other market conditions, including the war in Ukraine. In 2024, we anticipate that challenging market conditions, including those related to inflation and foreign currency exchange rate fluctuations, may continue to impact pricing. Price changes may affect net sales, earnings and market share in the near term as the market adjusts to new pricing and other market conditions.
Operating Costs - Our operating costs include raw materials, labor, selling, general and administrative expenses, general business taxes, currency impacts and financing costs. We manage these costs through cost saving and productivity initiatives, sourcing and hedging programs, and pricing actions. To remain competitive on our operating structure, we continue to work on programs to expand our profitability. While some costs moderated in 2023, they still remained elevated and our results were impacted by increased costs, particularly for pulp, resin, distribution, labor and energy, primarily related to COVID-19 pandemic driven effects and the effect of the war in Ukraine. In 2024, we expect that increased costs will continue to affect us, although at a decreasing rate of inflation compared to the prior fiscal year.
Evolving Consumer Product and Shopping Preferences - The retail landscape in many of our markets continues to evolve due to the rapid growth of e-commerce retailers, changing consumer preferences (as consumers increasingly shop online) and the increased presence of alternative retail channels, such as subscription services and direct-to-consumer businesses. Changing consumer preferences also include increased concerns in regard to post-consumer waste and packaging materials and their impact on environmental sustainability. If we experience lower sales due to changes in consumer demand for our products, our earnings could decrease. We believe our strategic growth focus, sustainability initiatives, innovation pipeline and continued investment in e-commerce capabilities has us well positioned relative to these changing dynamics.
Volatility of Global Markets - Our growth strategy depends in part on our ability to expand our operations, including in D&E Markets. Some D&E Markets have greater political, economic and currency volatility and greater vulnerability to infrastructure and labor disruptions. Volatility in these markets affects our production costs and the demand for our products and may impact our supply chain and distribution networks. Volatility in global consumer demand, commodity costs and foreign currency exchange rates increased significantly over the past few years and is expected to continue in the near term.
Climate Change - We operate in many regions around the world where our businesses could be disrupted by climate change. Our climate change risk categories include risks related to the transition to a lower-carbon economy (“Transition Risks”) and risks related to the physical impacts of climate change (“Physical Risks”). Transition Risks include increased costs of carbon emission, increased cost to produce products in compliance with future regulations, increased raw materials cost, shifts in customer/consumer values and other legal, regulatory and technological risks. Physical Risks include the risk of direct damage to assets or supply chain disruption caused by severe weather events such as floods, storms, wildfires and droughts. We continue to progress toward our 2030 Sustainability Goals which include elements that aim for reductions in greenhouse gas emissions, use of natural forest fibers, use of plastics and use of water in water-stressed regions.
War in Ukraine - Beginning in March 2022, we have implemented significant adjustments to our business in Russia. We have substantially curtailed media, advertising and promotional activity and suspended capital investments in our sole manufacturing facility in Russia. Consistent with the humanitarian nature of our products, we manufacture and sell only essential items in Russia, such as baby diapers and feminine pads, which are critical to the health and hygiene of women, girls and babies. Our Russia business has represented approximately 1 to 2 percent of our net global sales, operating profit and total assets. Our ability to continue our operations in Russia may change as the situation evolves. Our business in Russia is experiencing increased input costs, supply chain complexities, reduced consumer demand, restricted access to raw materials and production assets, and restricted access to financial institutions, as well as increased supply chain, professional services, monetary, currency, trade and payment/investment sanctions and related controls. We are actively monitoring the situation, and as the business, geopolitical and regulatory environment concerning Russia evolves, we may not be able to sustain the limited manufacture and sale of our products, and our assets may be partially or fully impaired. We are also monitoring the increased risk of cyber-based attacks as a result of the war in Ukraine and have implemented additional cybersecurity measures designed to address the evolving threat landscape.

20
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Results of Operations and Related Information
This section presents a discussion and analysis of net sales, operating profit and other information relevant to an understanding of 2023 results of operations.
Consolidated
Selected Financial ResultsYear Ended December 31
20232022Change
2023 vs. 2022
Net Sales:
North America$11,132 $10,663 +4 %
Outside North America9,552 9,799 -3 %
Intergeographic sales(253)(287)-12 %
Total Net Sales20,431 20,175 +1 %
Operating Profit:
North America2,475 2,071 +20 %
Outside North America1,056 979 +8 %
Corporate & Other(a)
(1,118)(412)N.M.
Other (income) and expense, net(a)
69 (43)N.M.
Total Operating Profit2,344 2,681 -13 %
Provision for income taxes(453)(495)-8 %
Share of net income of equity companies196 116 +69 %
Net Income Attributable to Kimberly-Clark Corporation1,764 1,934 -9 %
Diluted Earnings per Share5.21 5.72 -9 %
(a)    Corporate & Other and Other (income) and expense, net includes income and expenses not associated with the business segments, including adjustments as indicated in the Non-GAAP Reconciliations.
GAAP to Non-GAAP Reconciliations of Selected Financial Results
Twelve Months Ended December 31, 2023
As
Reported
Sale of Brazil Tissue and
K-C Professional Business
Impairment of Intangible AssetsPension SettlementsAs
Adjusted
Non-GAAP
Cost of products sold$13,399$15 $ $ $13,384
Gross Profit7,032(15)  7,047
Marketing, research and general expenses3,96115   3,946
Impairment of intangible assets658 658  
Other (income) and expense, net69(74)  143
Operating Profit2,34444 (658) 2,958
Nonoperating expense(96)  (35)(61)
Provision for income taxes(453)(18)175 9 (619)
Effective tax rate22.4 %   23.2 %
Net income attributable to noncontrolling interests 20  (20)
Net Income Attributable to Kimberly-Clark Corporation1,76426 (463)(26)2,227
Diluted Earnings per Share(a)
5.210.08 (1.36)(0.08)6.57


21
KIMBERLY-CLARK CORPORATION - 2023 Annual Report



Twelve Months Ended December 31, 2022
As
Reported
Acquisition of Controlling Interest in ThinxPension SettlementsAs
Adjusted
Non-GAAP
Marketing, research and general expenses$3,581 $21 $— $3,560 
Other (income) and expense, net(43)(85)— 42 
Operating Profit2,681 64 — 2,617 
Nonoperating expense
(73)— (52)(21)
Provision for income taxes(495)13 (512)
Effective tax rate21.2 %— — 22.0 %
Net Income Attributable to Kimberly-Clark Corporation
1,934 68 (39)1,905 
Diluted Earnings per Share(a)
5.72 0.20 (0.12)5.63 
(a)    "As Adjusted Non-GAAP" may not equal "As Reported" plus "Adjustments" as a result of rounding.
Analysis of Consolidated Results
Percent Change in Net Sales 2023 vs. 2022VolumeNet PriceMix/Other
Exited Business(e)
Currency
Total(a)
Organic(b)
Consolidated(2)61(1)(3)15
North America455
Developed & Emerging(5)82(2)(8)(6)5
Developed Markets(6)91(1)34
Percent Change in
Adjusted Operating Profit
2023 vs. 2022
VolumeNet PriceInput Costs
Cost Savings(c)
Currency Translation
Other(d)
Total
Twelve months ended(6)49(2)12(5)(35)13
(a)    Total may not equal the sum of volume, net price, mix/other, exited business and currency due to rounding and excludes intergeographic sales.
(b)    Combined impact of changes in volume, net price and mix/other.
(c)    Benefits of the FORCE (Focused On Reducing Costs Everywhere) program.
(d)    Includes impact of changes in product mix, marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
(e)    Impact of the sale of Brazil tissue and K-C Professional business.

Net sales of $20.4 billion increased 1 percent compared to the year ago period. Operating profit was $2,344 in 2023 and $2,681 in 2022. Adjusted operating profit was $2,958 in 2023 and $2,617 in 2022. Results benefited from higher net selling prices, $325 of cost savings from our FORCE program, and improved product mix, partially offset by higher marketing, research and general expenses, unfavorable foreign currency effects, higher other manufacturing costs, lower volumes and higher input costs.
Other (income) and expense, net was $69 of expense in 2023, which primarily reflected unfavorable foreign currency effects, including highly inflationary accounting adjustments, partially offset by the gain on the sale of the Brazil tissue and K-C Professional business. Other (income) and expense, net was $43 of income in 2022, which primarily reflected the non-recurring, non-cash gain recognized upon the acquisition of a controlling interest in Thinx related to the remeasurement of the carrying value of our previously held equity investment to fair value. Adjusted other (income) and expense, net was $143 and $42 of expense in 2023 and 2022, respectively.
The effective tax rate was 22.4 percent in 2023 compared to the effective tax rate of 21.2 percent in 2022. The adjusted effective tax rate was 23.2 percent in 2023 compared to 22.0 percent in 2022.

22
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Our share of net income of equity companies was $196 in 2023 and $116 in 2022. Kimberly-Clark de Mexico, S.A.B. de C.V. results in 2023 benefited from favorable foreign currency effects, higher net selling prices and cost savings, partially offset by higher input costs and general and administrative expenses.

Diluted earnings per share were $5.21 in 2023 and $5.72 in 2022. Adjusted earnings per share of $6.57 in 2023 increased 17 percent compared to $5.63 in 2022. The increase was primarily driven by higher adjusted operating profit and improved net income from our equity companies.
Business Segments
Personal Care
2023202220232022
Net Sales$10,691 $10,622 Operating Profit$1,890 $1,787 
Percent Change in Net Sales
 2023 vs. 2022
VolumeNet PriceMix/OtherCurrency
Total(a)
Organic(b)
Total Personal Care(1)51(5)15
North America1244
D&E Markets(4)92(11)(4)7
Developed Markets(5)61(2)3
Percent Change in
Operating Profit
 2023 vs. 2022
VolumeNet PriceInput Costs
Cost Savings(c)
Currency Translation
Other(d)
Total
Twelve months ended(1)31(3)8(6)(23)6
(a)    Total may not equal the sum of volume, net price, mix/other and currency due to rounding and excludes intergeographic sales.
(b)    Combined impact of changes in volume, net price and mix/other.
(c)    Benefits of the FORCE program.
(d)    Includes impact of changes in product mix, marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
Net sales of $10.7 billion increased 1 percent compared to the year ago period, while organic sales increased 5 percent driven by changes in net selling prices and product mix of 5 percent and 1 percent, respectively, partially offset by lower volumes of approximately 1 percent. Changes in foreign currency exchange rates decreased sales by approximately 5 percent. Changes in net selling prices and foreign currency exchange rates for D&E Markets were primarily driven by highly inflationary economies.
Operating profit of $1,890 increased 6 percent. Results benefited from higher net selling prices, cost savings and improved product mix, partially offset by higher marketing research and general expenses and unfavorable foreign currency effects.

23
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Consumer Tissue
2023202220232022
Net Sales$6,290 $6,243 Operating Profit$976 $806 
Percent Change in Net Sales
2023 vs. 2022
VolumeNet PriceMix/Other
Exited Business(e)
Currency
Total(a)
Organic(b)
Total Consumer Tissue(3)6(2)(1)13
North America555
D&E Markets(9)7(8)(3)(13)(2)
Developed Markets(5)9(1)44
Percent Change in
Operating Profit
2023 vs. 2022
VolumeNet PriceInput Costs
Cost Savings(c)
Currency Translation
Other(d)
Total
Twelve months ended(7)48(8)14(26)21
(a)    Total may not equal the sum of volume, net price, mix/other, exited business and currency due to rounding and excludes intergeographic sales.
(b)    Combined impact of changes in volume, net price and mix/other.
(c)    Benefits of the FORCE program.
(d)    Includes impact of changes in product mix, marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
(e)    Impact of the sale of Brazil tissue and K-C Professional business.
Net sales of $6.3 billion increased 1 percent compared to the year ago period, while organic sales increased 3 percent driven by changes in net selling prices of 6 percent, partially offset by lower volumes of 3 percent. Exited business decreased sales by approximately 2 percent, and changes in foreign currency exchange rates decreased sales by approximately 1 percent.
Operating profit of $976 increased 21 percent. Results benefited from higher net selling prices and cost savings, partially offset by higher other manufacturing costs, higher input costs, lower volumes and higher marketing research and general expenses.
K-C Professional
2023202220232022
Net Sales$3,404 $3,256 Operating Profit$665 $457 
Percent Change in Net Sales
2023 vs. 2022
VolumeNet PriceMix/Other
Exited Business(e)
Currency
Total(a)
Organic(b)
Total K-C Professional(5)101(1)(1)57
North America(2)988
D&E Markets(5)101(6)(6)(5)6
Developed Markets(13)13444
Percent Change in
Operating Profit
2023 vs. 2022
VolumeNet PriceInput Costs
Cost Savings(c)
Currency Translation
Other(d)
Total
Twelve months ended(14)731013(3)(33)46
(a)    Total may not equal the sum of volume, net price, mix/other, exited business and currency due to rounding and excludes intergeographic sales.
(b)    Combined impact of changes in volume, net price and mix/other.
(c)    Benefits of the FORCE program.
(d)    Includes impact of changes in product mix, marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
(e)    Impact of the sale of Brazil tissue and K-C Professional business.

24
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Net sales of $3.4 billion increased 5 percent compared to the year ago period, while organic sales increased 7 percent driven by changes in net selling prices and product mix of 10 percent and 1 percent, respectively, partially offset by lower volumes of 5 percent. The decrease in volumes primarily reflected expected elasticity from pricing actions. Exited business decreased sales by 1 percent, and changes in foreign currency exchange rates decreased sales by 1 percent.
Operating profit of $665 increased 46 percent. Results benefited from higher net selling prices, cost savings and lower input costs, partially offset by lower volumes, higher other manufacturing costs, higher marketing research and general expenses and unfavorable foreign currency effects.
Liquidity and Capital Resources
Cash Provided by Operations
Cash provided by operations was $3,542 in 2023 compared to $2,733 in 2022. The increase was driven by the increase in operating profit, excluding the effect of non-cash charges, and improvements in working capital.
Obligations
The following table presents our total contractual obligations for which cash flows are fixed or determinable. 
Total202420252026202720282029+
Long-term debt$7,993 $566 $559 $403 $601 $698 $5,166 
Interest payments on long-term debt
3,118 289 276 254 247 224 1,828 
Operating lease liabilities519 145 128 110 64 27 45 
Unconditional purchase obligations3,042 1,528 1,029 227 227 13 18 
Open purchase orders1,285 1,133 131 12 
Total contractual obligations
$15,957 $3,661 $2,123 $1,006 $1,144 $964 $7,059 
The unconditional purchase obligations are for the purchase of raw materials, primarily superabsorbent materials, pulp and utilities. Although we are primarily liable for payments on the above operating leases and unconditional purchase obligations, based on historic operating performance and forecasted future cash flows, we believe exposure to losses, if any, under these arrangements is not material.
The open purchase orders displayed in the table represent amounts for goods and services we have negotiated for delivery.
The table does not include amounts where payments are discretionary or the timing is uncertain. The following payments are not included in the table:
We will fund our defined benefit pension plans to meet or exceed statutory requirements and currently expect to contribute approximately $20 to these plans in 2024.
Other postretirement benefit payments are estimated using actuarial assumptions, including expected future service, to project the future obligations. Based upon those projections, we anticipate making annual payments for these obligations of approximately $50 through 2033.
Accrued income tax liabilities for uncertain tax positions, deferred taxes and noncontrolling interests.
Investing
Our capital spending was $766 in 2023 and $876 in 2022. Proceeds from asset and business dispositions of $245 primarily reflected the sale of our Brazil tissue and K-C Professional business. Acquisition of business, net of cash acquired of $46 in 2022 reflected the acquisition of a controlling interest of Thinx. We expect capital spending to be approximately $900 in 2024.
Financing
We issue long-term debt in the public market periodically. Proceeds from the offerings are used for general corporate purposes, including repayment of maturing debt or outstanding commercial paper indebtedness. See Item 8, Note 6 to the consolidated financial statements for details.

25
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Our short-term debt, which consists of U.S. commercial paper with original maturities up to 90 days and/or other similar short-term debt issued by non-U.S. subsidiaries, was $2 as of December 31, 2023 (included in debt payable within one year on the consolidated balance sheet). The average month-end balance of short-term debt for the twelve months ended December 31, 2023 was $139. These short-term borrowings provide supplemental funding to support our operations. The level of short-term debt generally fluctuates depending upon the amount of operating cash flows and the timing of customer receipts and payments for items such as pension contributions, dividends and income taxes.
At December 31, 2023, total debt was $8.0 billion compared to $8.4 billion at December 31, 2022.
In 2023, Cash paid for redemption of common securities of Thinx of $95 was to acquire the remaining ownership of Thinx. See Item 8, Note 3 to the consolidated financial statements for details.
We maintain a $2.0 billion revolving credit facility which expires in June 2028 and a $750 revolving credit facility which expires in May 2024.  These facilities, currently unused, support our commercial paper program, and would provide liquidity in the event our access to the commercial paper markets is unavailable for any reason.
In October 2021, members of the Organization for Economic Co-operation and Development/G20 Inclusive Framework on Base Erosion and Profit Shifting Project (“Inclusive Framework”) agreed to a two-pillar solution to reform the international tax framework to realign international taxation with economic activities and value creation. Inclusive Framework members agreed to a coordinated system of Global anti-Base Erosion rules, referred to as Pillar 2, that are designed to ensure large multinational enterprises pay a minimum 15 percent level of tax on the income arising in each jurisdiction in which they operate. Many countries have formally implemented Pillar 2, and several other countries have draft legislation to implement this framework. We do not expect Pillar 2 current and proposed legislation to materially impact our effective tax rate or cash flows. We will continue to monitor and evaluate new legislation and guidance, which could change our current assessment.
The United Kingdom’s Financial Conduct Authority, which regulated the London Interbank Offered Rate (“LIBOR”), has completed its phase out of LIBOR as of June 30, 2023. The effect of the elimination of LIBOR was not material.
We paid $1.6 billion in dividends in 2023. The Board of Directors approved a dividend increase of 3.4 percent for 2024. We repurchase shares of Kimberly-Clark common stock from time to time pursuant to publicly announced share repurchase programs. During 2023, we repurchased 1.8 million shares of our common stock at a cost of $225 through a broker in the open market.
We believe that our ability to generate cash from operations and our capacity to issue short-term and long-term debt are adequate to fund working capital, capital spending, pension contributions, dividends and other needs for the foreseeable future. Further, we do not expect restrictions or taxes on repatriation of cash held outside of the U.S. to have a material effect on our overall business, liquidity, financial condition or results of operations for the foreseeable future.

26
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Critical Accounting Policies and Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. The critical accounting policies we used in the preparation of the consolidated financial statements are those that are important both to the presentation of our financial condition and results of operations and require significant judgments by management with regard to estimates used. The critical judgments by management relate to accruals for sales incentives and trade promotion allowances, pension and other postretirement benefits, deferred income taxes and potential income tax assessments, and goodwill and other intangible assets. These critical accounting policies have been reviewed with the Audit Committee of the Board of Directors.
Sales Incentives and Trade Promotion Allowances
Trade promotion programs include introductory marketing funds such as slotting fees, cooperative marketing programs, temporary price reductions and other activities conducted by our customers to promote our products. Rebate and promotion accruals are based on estimates of the quantity of customer sales. Promotion accruals also consider estimates of the number of consumer coupons that will be redeemed and timing and costs of activities within the promotional programs. Generally, the estimated redemption value of consumer coupons and related expense are based on historical patterns of coupon redemption, influenced by judgments about current market conditions such as competitive activity in specific product categories, and the cost is recorded when the related revenue from customers is realized. Our related accounting policies are discussed in Item 8, Note 1 to the consolidated financial statements.
Employee Postretirement Benefits
Substantially all regular employees in the U.S. and the United Kingdom are covered by defined contribution retirement plans and certain U.S. and United Kingdom employees previously earned benefits covered by defined benefit pension plans that currently provide no future service benefit (the "Principal Plans"). Certain other subsidiaries have defined benefit pension plans or, in certain countries, termination pay plans covering substantially all regular employees. Our related accounting policies and account balances are discussed in Item 8, Note 8 to the consolidated financial statements.
Changes in certain assumptions could affect pension expense and the benefit obligations, particularly the estimated long-term rate of return on plan assets and the discount rate used to calculate the obligations:
Long-term rate of return on plan assets. The expected long-term rate of return is evaluated on an annual basis. In setting these assumptions, we consider a number of factors including projected future returns by asset class relative to the target asset allocation. Actual asset allocations are regularly reviewed and they are periodically rebalanced to the targeted allocations when considered appropriate.
As of December 31, 2023, the Principal Plans had cumulative unrecognized investment and actuarial losses of approximately $1.0 billion. These unrecognized net losses may increase future pension expense if not offset by (i) actual investment returns that exceed the assumed investment returns, (ii) other factors, including reduced pension liabilities arising from higher discount rates used to calculate pension obligations, or (iii) other actuarial gains, and whether such accumulated actuarial losses at each measurement date exceed the "corridor" as required. If the expected long-term rate of return on assets for the Principal Plans were lowered by 0.25 percent, the impact on annual pension expense would not be material in 2024.
Discount rate. The discount (or settlement) rate used to determine the present value of our future U.S. pension obligation at December 31, 2023 was based on a portfolio of high quality corporate debt securities with cash flows that largely match the expected benefit payments of the plan. For the United Kingdom plan, the discount rate was determined based on yield curves constructed from a portfolio of high quality corporate debt securities. Each year's expected future benefit payments were discounted to their present value at the appropriate yield curve rate to determine the pension obligations. If the discount rate assumptions for these same plans were reduced by 0.25 percent, the increase in annual pension expense would not be material in 2024, and the December 31, 2023 pension liability would increase by about $60.
Other assumptions. There are a number of other assumptions involved in the calculation of pension expense and benefit obligations, primarily related to participant demographics and benefit elections.

27
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Pension expense for defined benefit pension plans is estimated to approximate $50 in 2024. Pension expense beyond 2024 will depend on future investment performance, our contributions to the pension trusts, changes in discount rates and various other factors related to the covered participants in the plans.
Substantially all U.S. retirees and employees have access to our unfunded health care and life insurance benefit plans. Changes in significant assumptions could affect the consolidated expense and benefit obligations, particularly the discount rate used to calculate the obligations and the health care cost trend rate:
Discount rate. The determination of the discount rates used to calculate the benefit obligations of the plans is discussed in the pension benefit section above, and the methodology for each country is the same as the methodology used to determine the discount rate for that country's pension obligation. If the discount rate assumptions for these plans were reduced by 0.25 percent, the impact to 2024 other postretirement benefit expense and the increase in the December 31, 2023 benefit liability would not be material.
Health care cost trend rate. The health care cost trend rate is based on a combination of inputs including our recent claims history and insights from external advisers regarding recent developments in the health care marketplace, as well as projections of future trends in the marketplace.
Deferred Income Taxes and Potential Assessments
As a global organization, we are subject to income tax requirements in various jurisdictions in the U.S. and internationally. Changes in certain assumptions related to income taxes could significantly affect consolidated results, particularly with regard to valuation allowances on deferred tax assets, undistributed earnings of subsidiaries outside the U.S. and uncertain tax positions. Our income tax related accounting policies, account balances and matters affecting income taxes are discussed in Item 8, Note 13 to the consolidated financial statements.
Deferred tax assets and related valuation allowances. We have recorded deferred tax assets related to, among other matters, income tax loss carryforwards, income tax credit carryforwards and capital loss carryforwards and have established valuation allowances against these deferred tax assets. These carryforwards are primarily in non-U.S. taxing jurisdictions and in certain states in the U.S. Foreign tax credits earned in the U.S. in current and prior years, which cannot be used currently, also give rise to net deferred tax assets. In determining the valuation allowances to establish against these deferred tax assets, many factors are considered, including the specific taxing jurisdiction, the carryforward period, income tax strategies and forecasted earnings for the entities in each jurisdiction. A valuation allowance is recognized if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax asset will not be realized.
Undistributed earnings. As of December 31, 2023, we have accumulated undistributed earnings generated by our foreign subsidiaries of approximately $7.2 billion. Earnings of $3.3 billion were previously subject to U.S. federal income tax. Any additional taxes due with respect to such previously-taxed foreign earnings, if repatriated, would generally be limited to foreign and U.S. state income taxes. Deferred taxes have been recorded on $0.8 billion of earnings of foreign consolidated subsidiaries expected to be repatriated. We do not intend to distribute the remaining $2.5 billion of previously-taxed foreign earnings and therefore have not recorded deferred taxes for foreign and U.S. state income taxes on such earnings. We consider any excess of the amount for financial reporting over tax basis in our foreign subsidiaries to be indefinitely reinvested. The determination of deferred tax liabilities on the amount of financial reporting over tax basis or the $2.5 billion of previously-taxed foreign earnings is not practicable.
Uncertain tax positions. We record our global tax provision based on the respective tax rules and regulations for the jurisdictions in which we operate. Where we believe that a tax position is supportable for income tax purposes, the item is included in our income tax returns. Where treatment of a position is uncertain, a liability is recorded based upon the expected most likely outcome taking into consideration the technical merits of the position based on specific tax regulations and facts of each matter. These liabilities may be affected by changing interpretations of laws, rulings by tax authorities or the expiration of the statute of limitations.
Goodwill and Other Intangible Assets
Goodwill and other indefinite-lived intangible assets are not subject to amortization and are tested for impairment annually and whenever events or changes in circumstances indicate that impairment may have occurred. Intangible assets that are deemed to

28
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


have finite lives are amortized over their useful lives, generally ranging from 4 to 20 years. We typically obtain the assistance of third-party valuation specialists to measure the acquisition date fair values of goodwill and other intangible assets acquired.
Events and conditions that could result in impairment include a sustained drop in the market price of our common shares, increased competition or loss of market share, obsolescence, product claims that result in a significant loss of sales or profitability over the product life, deterioration in macroeconomic conditions, or declining financial performance in comparison to projected results.
Our related accounting policies, acquisition of Thinx and goodwill and other intangible assets account balances and other intangible asset impairment charges are discussed in Item 8, Notes 1, 3 and 4, respectively, to the consolidated financial statements.
Goodwill
In our evaluation of goodwill impairment, we have the option to first assess qualitative factors such as macroeconomic, industry and competitive conditions, legal and regulatory environments, historical and projected financial performance, significant changes in the reporting unit and the magnitude of excess fair value over carrying amount from the previous quantitative impairment testing. If the result of a qualitative test indicates a potential for impairment, a quantitative test is performed. When a quantitative test is considered necessary, estimates of fair value for goodwill impairment testing are determined based on a discounted cash flow model and a market-based approach. We use inputs from our long-range planning process to determine growth rates for sales and earnings. The other key estimates and factors used in the discounted cash flow include, but are not limited to, discount rates, actual business trends experienced, commodity prices, foreign exchange rates, inflation and terminal growth rates.
For 2023, we completed the required annual assessment of goodwill for impairment for all of our reporting units using a qualitative assessment as of the first day of the third quarter, and we determined that it is more likely than not that the fair value of goodwill significantly exceeds the carrying amount for each of our reporting units.
Other Intangible Assets
We evaluate the useful lives of our other intangible assets, primarily brands, to determine if they are finite or indefinite-lived. Reaching a determination on useful life requires significant judgments and assumptions regarding the future effects of obsolescence, demand, competition, other economic factors (such as the stability of the industry, known technological advances and expected changes in distribution channels), the level of required maintenance expenditures, and the expected lives of other related groups of assets.
Our estimate of the fair value of our brand assets is based on a discounted cash flow model and a market-based approach using inputs which include projected revenues from our long-range plan, assumed royalty rates that could be payable if we did not own the brands, and a discount rate. The cash flows used in the discounted cash flow model are consistent with those we use in our internal planning, which gives consideration to actual business trends experienced and the long-term business strategy.
We performed our 2023 impairment assessment of our intangible assets as of the first day of the third quarter, subsequent to the impairments recognized in the second quarter of 2023, and based upon a qualitative assessment, no additional impairment indicators were found to be present. See Item 8, Note 4 to the consolidated financial statements for details.
New Accounting Standards
See Item 8, Note 1 to the consolidated financial statements for a description of recent accounting standards and their anticipated effects on our consolidated financial statements.
Forward Looking Statements
Certain matters contained in this report concerning the business outlook, including raw material, energy and other input costs, the anticipated cost savings from our FORCE program, cash flow and uses of cash, growth initiatives, innovations, marketing and other spending, net sales, anticipated currency rates and exchange risks, including the impact in Argentina and Türkiye, effective tax rate, contingencies and anticipated transactions of Kimberly-Clark, including dividends, share repurchases and pension contributions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and are based upon management's expectations and beliefs concerning future events impacting Kimberly-Clark. 

29
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


There can be no assurance that these future events will occur as anticipated or that our results will be as estimated.  Forward-looking statements speak only as of the date they were made, and we undertake no obligation to publicly update them. 
The assumptions used as a basis for the forward-looking statements include many estimates that, among other things, depend on the achievement of future cost savings and projected volume increases. In addition, many factors outside our control, including the war in Ukraine (including the related responses of consumers, customers, and suppliers and sanctions issued by the U.S., the European Union, Russia or other countries), pandemics, epidemics, fluctuations in foreign currency exchange rates, the prices and availability of our raw materials, supply chain disruptions, disruptions in the capital and credit markets, counterparty defaults (including customers, suppliers and financial institutions with which we do business), failure to realize the expected benefits or synergies from our acquisition and disposition activity, impairment of goodwill and intangible assets and our projections of operating results and other factors that may affect our impairment testing, changes in customer preferences, severe weather conditions, regional instabilities and hostilities (including the war in Israel), government trade or similar regulatory actions, potential competitive pressures on selling prices for our products, energy costs, general economic and political conditions globally and in the markets in which we do business, as well as our ability to maintain key customer relationships, could affect the realization of these estimates.
The factors described under Item 1A, "Risk Factors" in our Form 10-K, or in our other SEC filings, among others, could cause our future results to differ from those expressed in any forward-looking statements made by us or on our behalf. Other factors not presently known to us or that we presently consider immaterial could also affect our business operations and financial results.
ITEM 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As a multinational enterprise, we are exposed to risks such as changes in foreign currency exchange rates, interest rates and commodity prices. A variety of practices are employed to manage these risks, including operating and financing activities and, where deemed appropriate, the use of derivative instruments. Derivative instruments are used only for risk management purposes and not for speculation. Foreign currency derivative instruments are primarily entered into with major financial institutions. Our credit exposure under these arrangements is limited to agreements with a positive fair value at the reporting date. Credit risk with respect to the counterparties is actively monitored but is not considered significant since these transactions are executed with a diversified group of financial institutions.
Presented below is a description of our risks (foreign currency risk and interest rate risk) together with a sensitivity analysis, performed annually, of each of these risks based on selected changes in market rates and prices. These analyses reflect management's view of changes which are reasonably possible to occur over a one-year period. Also included is a description of our commodity price risk.
Foreign Currency Risk
A portion of our foreign currency risk is managed through the systematic use of foreign currency forward contracts.  The use of these instruments supports the management of transactional exposures to exchange rate fluctuations as the gains or losses incurred on the derivative instruments will offset, in whole or in part, gains or losses on the underlying foreign currency exposure.  We also utilize cross currency swaps and foreign denominated debt to hedge certain investments in foreign subsidiaries.  The gain or loss on these instruments is recognized in other comprehensive income to offset the change in value of the net investments being hedged.
Foreign currency contracts and transactional exposures are sensitive to changes in foreign currency exchange rates. An annual test is performed to quantify the effects that possible changes in foreign currency exchange rates would have on annual operating profit based on our foreign currency contracts and transactional exposures at the current year-end. The balance sheet effect is calculated by multiplying each affiliate's net monetary asset or liability position by a 10 percent change in the foreign currency exchange rate versus the U.S. dollar.
As of December 31, 2023, a 10 percent unfavorable change in the exchange rate of the U.S. dollar against the prevailing market rates of foreign currencies involving balance sheet transactional exposures would not be material to our consolidated financial position, results of operations or cash flows. This hypothetical loss on transactional exposures is based on the difference between the December 31, 2023 rates and the assumed rates.

30
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


Our operations in Argentina ("K-C Argentina") are reported using highly inflationary accounting and their functional currency is the U.S. dollar. Changes in the value of an Argentine peso versus the U.S. dollar applied to our net peso monetary position are recorded in Other (income) and expense, net at the time of the change. As of December 31, 2023, K-C Argentina had an immaterial net peso monetary position and a 10 percent unfavorable change in the exchange rate would not be material.
As of April 1, 2022, we elected to adopt highly inflationary accounting for our operations in Türkiye (“K-C Türkiye”), and their functional currency is also the U.S. dollar. Changes in the value of a Turkish lira versus the U.S. dollar applied to our net lira monetary position are recorded in Other (income) and expense, net at the time of the change. As of December 31, 2023, K-C Türkiye had an immaterial net lira monetary position and a 10 percent unfavorable change in the exchange rate would not be material.
The translation of the balance sheets of non-U.S. operations from local currencies into U.S. dollars is also sensitive to changes in foreign currency exchange rates. Consequently, an annual test is performed to determine if changes in currency exchange rates would have a significant effect on the translation of the balance sheets of non-U.S. operations into U.S. dollars. These translation gains or losses are recorded as unrealized translation adjustments ("UTA") within stockholders' equity. The hypothetical change in UTA is calculated by multiplying the net assets of these non-U.S. operations by a 10 percent change in the currency exchange rates. As of December 31, 2023, a 10 percent unfavorable change in the exchange rate of the U.S. dollar against the prevailing market rates of our foreign currency translation exposures would have reduced stockholders' equity by approximately $600. In the view of management, the above potential UTA adjustments resulting from these assumed changes in foreign currency exchange rates are not material to our consolidated financial position because they would not affect our cash flow.
Interest Rate Risk
Interest rate risk is managed through the maintenance of a portfolio of variable and fixed-rate debt composed of short and long-term instruments. The objective is to maintain a cost-effective mix that management deems appropriate. At December 31, 2023, the long-term debt portfolio was comprised of primarily fixed-rate debt. From time to time, we also hedge the anticipated issuance of fixed-rate debt and those contracts are designated as cash flow hedges.
In order to determine the impact of changes in interest rates on our financial position or future results of operations, we calculated the increase or decrease in the market value of fixed-rate debt using a 10 percent change in current market interest rates and the rates governing these instruments. At December 31, 2023, a 10 percent decrease in interest rates would have increased the fair value of unhedged fixed-rate debt by about $347, which would not have a significant impact on our financial statements as we do not record unhedged fixed-rate debt at fair value.
Commodity Price Risk
We are subject to commodity price risk, the most significant of which relates to the price of pulp and petroleum-based materials. Selling prices of products are influenced, in part, by the market price for these pulp and petroleum-based materials. As previously discussed under Item 1A, "Risk Factors," increases in pulp or petroleum-based material prices could adversely affect earnings if selling prices are not adjusted or if such adjustments significantly trail the increases in commodity prices. In some instances, we use contracts of varying durations along with strategic pricing mechanisms to manage volatility for a portion of our commodity costs, but derivative instruments have not been used to manage these risks.
Our energy, manufacturing and transportation costs are affected by various market factors including the availability of supplies of particular forms of energy, energy prices and local and national regulatory decisions. As previously discussed under Item 1A, "Risk Factors," there can be no assurance we will be fully protected against substantial changes in the price or availability of energy sources. In addition, we are subject to price risk for utilities and manufacturing inputs, used in our manufacturing operations. Derivative instruments are used in accordance with our risk management policy to hedge a portion of the price risk.

31
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
 
KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED INCOME STATEMENTS
Year Ended December 31
(Millions of dollars, except per share amounts)202320222021
Net Sales$20,431 $20,175 $19,440 
Cost of products sold13,399 13,956 13,452 
Gross Profit7,032 6,219 5,988 
Marketing, research and general expenses3,961 3,581 3,399 
Impairment of intangible assets658   
Other (income) and expense, net69 (43)28 
Operating Profit2,344 2,681 2,561 
Nonoperating expense(96)(73)(86)
Interest income66 14 6 
Interest expense(293)(282)(256)
Income Before Income Taxes and Equity Interests
2,021 2,340 2,225 
Provision for income taxes(453)(495)(479)
Income Before Equity Interests1,568 1,845 1,746 
Share of net income of equity companies196 116 98 
Net Income1,764 1,961 1,844 
Net income attributable to noncontrolling interests (27)(30)
Net Income Attributable to Kimberly-Clark Corporation$1,764 $1,934 $1,814 
Per Share Basis
Net Income Attributable to Kimberly-Clark Corporation
Basic$5.22 $5.73 $5.38 
Diluted$5.21 $5.72 $5.35 
See notes to the consolidated financial statements.

32
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Year Ended December 31
(Millions of dollars)202320222021
Net Income$1,764 $1,961 $1,844 
Other Comprehensive Income (Loss), Net of Tax
   Unrealized currency translation adjustments89 (355)(288)
   Employee postretirement benefits(15)103 122 
   Cash flow hedges and other12 (185)84 
Total Other Comprehensive Income (Loss), Net of Tax86 (437)(82)
Comprehensive Income1,850 1,524 1,762 
   Comprehensive income attributable to noncontrolling interests1 (19)(15)
Comprehensive Income Attributable to Kimberly-Clark Corporation$1,851 $1,505 $1,747 
See notes to the consolidated financial statements.

33
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
December 31
(Millions of dollars)20232022
ASSETS
Current Assets
Cash and cash equivalents$1,093 $427 
Accounts receivable, net2,135 2,280 
Inventories1,955 2,269 
Other current assets520 753 
Total Current Assets5,703 5,729 
Property, Plant and Equipment, Net7,913 7,885 
Investments in Equity Companies306 238 
Goodwill2,085 2,074 
Other Intangible Assets, Net197 851 
Other Assets1,140 1,193 
TOTAL ASSETS$17,344 $17,970 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Debt payable within one year$567 $844 
Trade accounts payable3,653 3,813 
Accrued expenses and other current liabilities2,316 2,289 
Dividends payable394 388 
Total Current Liabilities6,930 7,334 
Long-Term Debt7,417 7,578 
Noncurrent Employee Benefits669 654 
Deferred Income Taxes374 647 
Other Liabilities860 799 
Redeemable Common and Preferred Securities of Subsidiaries26 258 
Stockholders' Equity
Kimberly-Clark Corporation
Preferred stock - no par value - authorized 20.0 million shares, none issued
  
Common stock - $1.25 par value - authorized 1.2 billion shares;
issued 378.6 million shares at December 31, 2023 and 2022
473 473 
Additional paid-in capital878 679 
Common stock held in treasury, at cost - 41.6 and 41.1 million
shares at December 31, 2023 and 2022, respectively
(5,222)(5,137)
Retained earnings8,368 8,201 
Accumulated other comprehensive income (loss)(3,582)(3,669)
Total Kimberly-Clark Corporation Stockholders' Equity915 547 
Noncontrolling Interests153 153 
Total Stockholders' Equity1,068 700 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $17,344 $17,970 
See notes to the consolidated financial statements.

34
KIMBERLY-CLARK CORPORATION - 2023 Annual Report


KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Millions of dollars, shares in thousands, except per share amounts)Common Stock
Issued
Additional
Paid-in
Capital
Treasury StockRetained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Non-
controlling
Interests
Total Stockholders'
Equity
SharesAmountSharesAmount
Balance at December 31, 2020378,597 $473 $657 39,873 $(4,899)$7,567 $(3,172)$243 $869 
Net income in stockholders' equity, excludes redeemable interests' share
— — — — — 1,814 — 29 1,843 
Other comprehensive income, net of tax, excludes redeemable interests' share
— — — — — — (67)(14)(81)
Stock-based awards exercised or vested
— — (80)(1,339)146 — — — 66 
Shares repurchased— — — 3,228 (430)— — — (430)
Recognition of stock-based compensation
— — 26 — — — — — 26 
Dividends declared ($4.56 per share)
— — — — — (1,538)— (36)(1,574)
Other
— — 2 — — 15 — 1 18 
Balance at December 31, 2021378,597 473 605 41,762 (5,183)7,858 (3,239)223 737 
Net income in stockholders' equity, excludes redeemable interests' share
— — — — — 1,934 — 38 1,972 
Other comprehensive income, net of tax, excludes redeemable interests' share
— — — — — — (429)(9)(438)
Stock-based awards exercised or vested
— — (86)(1,406)145 — — — 59 
Shares repurchased— — — 779 (100)— — — (100)
Recognition of stock-based compensation
— — 147 — — — — — 147 
Dividends declared ($4.64 per share)
— — — — — (1,566)— (98)(1,664)
Other
— — 13 — 1 (25)(1)(1)(13)
Balance at December 31, 2022378,597 473 679 41,135 (5,137)8,201 (3,669)153 700 
Net income in stockholders' equity, excludes redeemable interests' share